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Rbm24 was recently identified as a gene expressed during early mouse cardiac 
development (Miller et al., 2008). Due to its tightly restricted and persistent expression 
from formation of the cardiac crescent onwards and later in forming somites we posited 
it to be a key player in cardiovascular development and somitogenesis.  
To determine the role of this gene in cardiac development, we have identified its 
zebrafish orthologs (rbm24a and rbm24b), and functionally evaluated them during 
zebrafish embryogenesis.  Consistent with our underlying hypothesis, reduction in 
expression of either homolog through injection of morpholino antisense 
oligonucleotides results in cardiogenic defects including cardiac looping and reduced 
circulation, leading to increasing pericardial edema over time.  Additionally, morphant 
embryos for either ortholog display incompletely overlapping defects in the forming 
vasculature of the dorsal aorta (DA), posterior caudal vein (PCV) and caudal vein (CV) 
which are the first blood vessels to form in the embryo, with additional apparent 
impairment to  angiogenesis.    
This work goes on to demonstrate that both Rbm24a and Rbm24b are also 
required for proper somite and craniofacial development.  Investigations into early 
developmental pathways revealed diminution of rbm24a or rbm24b gene products by 
morpholino knockdown resulted in significant reduction of Notch-mediated signaling.  
Subsequent characterization of Notch-pathway components revealed reduced 
expression of the cyclic muscle pattering genes dlc and dld encoding Notch-ligands, and 
their respective target genes her1, her7 in rbm24a or rbm24b morpholino-injected 
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embryos. Analysis of affected Notch-pathway mRNA populations in rbm24a and 
rbm24b morpholino injected embryos revealed aberrant splice fragments of dlc and dld, 
but not her1 or her7.  The integrity of Notch-receptor mRNA was similarly unaffected, 
suggesting the origins of the observed Notch-signaling deficit is derived from aberrant 
splicing of its ligands.  
Taken together these data imply a previously unknown requirement for Rbm24a 
and Rbm24b in normal cardiovascular somite and craniofacial development. Further 
they suggest these protiens may play a crucial role in modulating Notch-mediated 
signaling through RNA post-transcriptional processing of dlc and dld. 
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1.1 RNA Recognition Motifs 
RNA Recognition Motifs (RRMs) are the most common and best characterized 
protein domains (Finn et al., 2006).  Classically in the literature this protein domain is 
known by several additional names, including RNA binding domain (RBD) or 
ribonucleoprotein domain (RNP) (Maris et al., 2005; Whittock et al.).  The general 
primary structure of the RRM domain was first identified in the late 1980’s as 
consisting of approximately 90 amino acids with two internal highly conserved sub-
domains.  These sub-domains are termed RNP1 consisting of 8 amino acids and RNP2 
consisting of 6 amino acids, and are spaced approximately 20-40 amino acids apart, 
with RNP2 at the N-terminus of the RRM domain.  The consensus sequences have been 
identified as (Lys/Arg)-Gly-(Phe/Tyr)-(Gly/Ala)-(Phe/Tyr)-(Val/Ile/Leu)-X-(Phe/Tyr) 
for RNP1 and (Ile/Val/Leu)-(Phe/Tyr)-(Ile/Val/Leu)-X-Asn-Leu for RNP2 where X 
represents any amino acid (Adam et al., 1986; Dreyfuss et al., 1988; Swanson et al., 
1987).  Mutagenesis studies on the properties of the RNP1 and RNP2 sub-domains 
indicate these consensus sequences are necessary for RRM motif binding as well as 
sufficient to confer RNA binding capacity (Bandziulis et al., 1989; Birney et al., 1993; 
Kenan et al., 1991) 
The RRM secondary structure is composed of four-stranded anti-parallel β-
sheets with two helices packed against it such that the domain has the split αβ 
(β4α2β1β3α2β2) topology.  The RNP1 sub-domain is located in the β3 β-sheet while 
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RNP2 is located in the β1 β-sheet (Oubridge et al., 1994; Swanson et al., 1987). Often, 
RRMs function in concert to increase binding specificity possibly because the number 
of nucleotides recognized by a single RRM is generally too small (4-6 nucleotides) to 
define a unique binding sequence (Auweter et al., 2006).  RRMs are found in a variety 
of RNA binding proteins throughout eukaryotic cells which encompass virtually all 
post-transcriptional processes including (for example), pre-mRNA processing (La 
protein), splicing (U2AF or hnRNPA1) alternative splicing (SR proteins or hnRNPA1), 
mRNA stability (CBP20), mRNA export (TLS), RNA editing (ACF), pre-rRNA 
complex formation (nucleolin) and translation regulation (PABP) (Birney et al., 1993).  
The diverse roles of proteins with RRM domains suggest these motifs are important for 
cellular development and function. 
 
1.2 RBM proteins 
RNA Binding Motif (RBM) genes encode a diverse protein family defined by the 
shared presence of RNA-binding motifs (RBMs) which are defined as containing one or 
more RRM.  Genes encoding RBM proteins are found throughout eukaryotes with at 
least 38 human RBM genes identified to date (Chen and Varani, 2005; Chen and Varani, 
2013). 
Little is known about the functions of the majority of RBM proteins.  Recent 
reports on RBM3 (Jayasena and Bronner, 2012), RBM4 (Lin et al., 2013), RBM8A 
(Albers et al., 2012) and RBM38 (Miyamoto et al., 2009), however, reveal potentially 
important developmental roles for these genes in such processes as craniofacial, 
pancreas, skeleton and muscle development. Thus far, dysfunctional RBM gene 
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products have been causally implicated in four human developmental disorders.  Null or 
hypomorphic RBM8A alleles cause thrombocytopenia with absent radii (TAR 
syndrome) (Albers et al., 2012). X-linked syndrome talipes equinovarus, atrial septal 
defect, Robin sequence, persistence of the left superior vena cava (TARP syndrome) is 
caused by mutations in RBM10 (Johnston et al., 2010), whereas a heritable dilated 
cardiomyopathy in which the pre-mRNA of the cardiac splice variant of TITIN is 
incorrectly processed results from mutations in RBM20 (Guo et al., 2012; Li et al., 
2013). Lastly, alopecia, progressive neurological defects and endocrinopathy (ANE 
syndrome) are caused by loss-of-function mutations in RBM28 (Nousbeck et al., 2008). 
 
2.2.1 RBM24 
RBM24 has emerged as a gene of interest in early cardiac development (Maragh 
et al.; Miller et al., 2008).  This gene was first associated with cardiac development as a 
result of a transcriptional profiling study by Miller et. al., 2008 where transgenic mouse 
embryonic stem cells possessing a GFP labeled early cardiac marker (Nkx2.5) were 
differentiated towards cardiac cell fates. Transcript populations from GFP positive 
mouse embryonic stem cells were compared to those of the GFP negative mouse 
embryonic stem cells in an effort to uncover novel critical cardiac genes.  A total of 176 
transcripts unique to the GFP positive cell population were identified with 43/176 
having known roles in early cardiac development. A significant fraction (31/133) of the 
remaining transcripts not previously reported to be expressed in cardiac progenitors or 
during cardiogenesis was selected for validation via mouse whole embryo RNA in situ 
hybridization at stages E7.5 (cardiac crescent), E8.5 (heart tube) and E9.5 (looping 
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heart). The resulting spatial and temporal expression patterns confirmed all 31 
transcripts evaluated were expressed in cardiac populations during cardiac development.  
Furthermore, 9 of these transcripts were expressed in the forming cardiac crescent at 
E7.5 of the mouse embryo, consistent with roles in the earliest stages of heart 
development. Based on the early cardiac expression of these genes we predicted they 
likely play significant roles in heart development. Of the 9 transcripts with expression in 
the cardiac crescent at E7.5, Rbm24 had the strongest expression in the cardiac crescent 
and showed strong primarily cardiac restricted expression at E8.5 and E9.5 (Figure 1-1). 
Of note by E9.5 Rbm24 was also expressed in skeletal muscle precursors.  The study 
from Miller et. al. 2008 presents Rbm24 as a gene of interest in early cardiac 
development and potentially of interest in skeletal muscle development.  Human 
RBM24 codes for proteins of unknown but likely important function, as its homologs 
are conserved though mammals and vertebrates down to worms.  This thesis will 
present functional studies using a zebrafish animal model system to study RBM24 in an 
attempt to uncover any functional or biological requirement for RBM24 in cardiac or 
skeletal muscle development.   
 
1.3 Cardiovascular development 
During vertebrate embryogenesis the heart is the first organ to develop and 
achieve functionality.  Model organism studies have uncovered a number of genes such 
as Nkx2.5, which have important functions in early vertebrate myocardial development 
and differentiation (Lints et al., 1993; Stainier et al., 1996).  Despite an increasing body 
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of data illuminating the roles played by several key genes during cardiac development, 
there is still much to learn about what other factors may be critical.  
The general stages of cardiac development are invariable throughout vertebrate 
model organisms where heart development has been examined, with zebrafish 
progressing through these stages at a particularly rapid rate (Bakkers, 2011) (Table 1-1).  
Following the completion of gastrulation, the heart filed is the first cardiac structure to 
form consisting of linearly oriented atrial and ventricular precursor cells.  This is 
followed by the development of the cardiac crescent (heart cone in zebrafish) by the 
movement and expansion of atrial and ventricular cell precursors and the development 
of endocardium.  This structure expands and elongates into a heart tube, at which point 
the nascent ventricular and atrial chambers can be distinguished and myocardial 
contraction begins.  The heart tube undergoes a multiple specification events, including 
early chamber formation, atrio-ventricuar septation, and turning of the heart tube.  
Primordial cardiac formation completes with the looping of the heart tube to form a 
functional chambered heart.  Heart looping is completed in humans by embryo day 25-
28, in mouse by embryo day 9-10 and in zebrafish by 48 hours post fertilization (hpf) or 
the equivalent of embryo day 2 (Evans et al., 2010); (Bruneau, 2008). 
Zebrafish have been shown to be a powerful and relevant model system to study 
cardiac development (Bakkers, 2011; de Pater et al., 2009; Poon et al., 2010; Stainier, 
2001).  Zebrafish progress through early heart development, to the stage of a looped 
heart with circulation, approximately 5 times faster than mouse and 12 times faster than 
humans.  For zebrafish the heart field forms by 13 hpf, with a heart cone between 19-20 
hpf, followed by the formation of a short cardiac tube lacking discrete chambers by 24 
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hpf.  Subsequent cardiac tube lengthening and distinct chambers are discernable by 30 
hpf with heart tube turning occurring around 36 hpf.  A looped functional two 
chambered zebrafish heart is visible by 48 hpf (Stainier, 2001) (Figure 1-2).   
Cardiac development occurs in concert with vascular development.  Vascular 
development consists of vasculogenesis which is the de novo formation of the first 
vascular vessels and subsequently angiogenesis which is the formation of additional 
vasculature as extensions of existing vasculature.  Zebrafish vasculogenesis results in 
the formation of the main trunk vessels with the DA first to form (24 – 26 hpf) followed 
by the CV (Albers et al.) and the PCV (28 – 30 hpf) and several heart vessels generating 
the first single circulation loop.  Angiogenesis can be observed in the trunk by 24 hpf as 
intersegmental vessels (Se) begin to form as paired dorsally extending branches off the 
DA and subsequently off the PCV (~32 hpf).  As the Se reach the dorsal line of the 
embryo the ends of the vessels form connections resulting in two dorsal longitudinal 
anastomotic vessels (DLAVs) running along the anterior-posterior (Goodrich et al.) axis 
of the embryo at the dorsal line. By 48 hpf these trunk vessels are fully formed with 
circulation (Ellertsdottir et al., 2010; Isogai et al., 2001).  Zebrafish transgenic lines and 
whole embryo staining techniques have been developed and used successfully to study 
vascular development and circulation (Cross et al.; Drake et al., 1997; Hogan et al., 
2009). 
 
1.4 Somite development 
Somites are developmental tissue blocks derived from the paraxial mesoderm.  
Structurally somites are paired tissue segments (one either side of the midline) along the 
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trunk of the developing embryo (Gridley, 2006; Pourquie, 2011) (Figure 1-3).  Somites 
give rise to skeletal muscle (myotome), cartilage of vertebrae (sclerotome), dermis 
(dermatome) and endothelial cells (Maroto et al., 2012; Stickney et al., 2000).  After the 
completion of gastrulation, a niche within the tailbud  of the embryo containing 
multipotent mesodermal progenitor cells (MPCs), provides the precursors that 
ultimately differentiate and organize into somite blocks (Kimelman, 2006; Szeto and 
Kimelman, 2006).  As an embryo continues to develop, the tailbud extends posteriorly 
and MPCs being to populate a zone called the pre-somitic mesoderm (PSM) just 
anterior to the tailbud and differentiate into myotome, dermatome and sclerotome 
precursors.  Myotome precursors form both the myotome progenitor population of the 
somite and the embryonic precursor cells to slow muscle fibers called adaxial cells. 
Myogenic regulatory factors (MRFs) Myf5, Myod, Myog and Myf6 are pivotal 
components of myogenesis, and their genes are expressed sequentially in myotome 
precursors beginning with myf5 in the PSM, adaxial cells and nascent segmenting 
somites. This is followed by myod expression in adaxial cells, nascent segmenting 
somites and mature segmented somites, contributing to somite patterning and 
maturation of myoblasts.  Myoblast fusion to form myofibers then terminally 
differentiated myotubes requires myog and myf6 expression (Coutelle et al., 2001; 
Osborn et al., 2011). 
Maintenance of the MPC niche and continuous somite segmenting with the 
appropriate periodicity (~every 30 minuets) is critical for normal skeletal muscle, 
cartilage, dermis and vascular development (Maroto et al., 2012; Stickney et al., 2000).  
Normal development requires coordinated regulation of signaling for both the 
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segmentation of new somites and the patterning of formed somites. Components of the 
Wnt, FGF, Shh, BMP and Notch developmental pathways have been shown in model 
organisms to be required for normal somitogenesis (Bryson-Richardson and Currie, 
2008; Jiang et al., 2000; Marcelle et al., 1997; Niwa et al., 2011; Sawada et al., 2001; 
Tiedemann et al., 2012).  Zebrafish mutants for gli2a, ntla, smad5, bmp7a, tbx6, tbx16, 
dlc, dld or notch1a have dysregulated somitogenesis and aberrantly formed somites 
(van Eeden et al., 1996).  It is plausible that dysregulation of these critical 
developmental pathways underlies developmental disorders of as yet unknown etiology.   
 
1.5 The Notch-signaling pathway and somitogenesis 
Notch-mediated signaling is among several pathways that play key roles in 
segmentation and somite patterning (Bray, 2006; High and Epstein, 2008; Oates and 
Ho, 2002). The Notch pathway acts via a complex multi-component path to achieve 
paracrine signaling.  A simplified model of this pathway can be stated as cell surface 
ligands interacting with cell surface receptors on a neighboring cell to activate the 
expression of a target gene within that cell (Bray, 2006).  Specifically, ligands Dlc and 
Dld and target genes Her1 and Her7 have been shown in zebrafish to be critical 
components of somitogenesis and the segmentation clock, signaling within MPCs, the 
PSM and nascent segmenting somites (Giudicelli et al., 2007; Julich et al., 2005; Oates 
et al., 2005; Schroter et al., 2012; Trofka et al., 2012) (Figure 1-4).  The genes encoding 
these four proteins are commonly referred to as the somite clock genes.  Dlc and Dld 
ligands function to activate transcription of her1 and her7 target genes in neighboring 
cells by signaling through Notch1a and Notch3 receptors (Giudicelli et al., 2007; Oates 
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et al., 2005).  The normal functions of Her1 and Her7, include negative regulation of dlc 
and dld transcription which contributes to both perpetuation of the somite clock and 
maintenance of unsegmented cells within the PSM (Tiedemann et al., 2012).  The 
cycling expression of these ligands and target genes persists through to the completion 
of somitogenesis and is partially maintained by negative feedback of target gene 
proteins on transcription of dlc and dld (Giudicelli et al., 2007; Holley et al., 2000).   
Thus far Notch pathway dysregulation has been implicated as causal for two 
human disorders involving tissues of somite origin.  These are Alagille Syndrome and 
spondylocostal dysostosis (Shifley and Cole, 2007).  In Alagille Syndrome 
somitogenesis is believed to be impaired due to patients presenting with skeletal 
deformities and facial abnormalities with cardiac disease also prevalent.  Several studies 
have linked loss of activity of the Notch ligand Jagged1 to the pathogenicity of Alagille 
Syndrome (Li et al., 1997; McCright et al., 2002; Oda et al., 1997; Spinner et al., 2001).  
Spondylocostal dysostosis represents a family of disorders all sharing the feature of 
short trunk dwarfism accompanied by vertebral segmentation defects along the length 
of the spinal column, with studies identifying mutations in Notch Ligand DLL3 as 
causal for the disorder (Penton et al., 2012; Shifley and Cole, 2007; Whittock et al., 
2004). 
 
1.6 Functional studies in a zebrafish model 
 Danio rerio commonly known as zebrafish is a powerful model system to 
observe and functionally evaluate processes of early development due to their natural 
characteristics as well as their easy manipulation with molecular-genetic techniques.  
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Zebrafish fertilization and development occur externally with a single male and female 
mating yielding up to hundreds of embryos.  These embryos are initially transparent 
allowing for in vivo visualization and imaging of early developing tissues.  Chemicals 
such as 1-phenyl 2-thiourea (PTU) can be used to inhibit melanocyte development 
allowing for continued in vivo visualization of development through the embryonic 
stage.  These characteristics coupled with a generation time of 3 months present 
zebrafish as an attractive system in which to investigate early development (Kimmel et 
al., 1995; Westerfield, 1995). 
 A variety of molecular genetic tools have been developed for studying 
development in zebrafish both in vivo and in vitro.  Among the most common tools used 
are microinjection, microscopy and whole embryo staining.  Through microinjection, 
exogenous plasmids, RNAs or morpholinos (MOs) are directly introduced into the 
zebrafish embryo between 1-4 cell stages.  The purposes of such manipulation include 
generation of tagged transgenic zebrafish lines, over expression models and knockdown 
models (Pickart and Klee, 2014).   MOs are short oligos (~ 25 bp) with a morpholine 
backbone designed to result in knockdown of protein levels through targeted 
complementary binding to RNA.  MOs can act via splice-blocking (causing mis-
processing of pre-mRNAs by binding to and occluding splice junctions) or translation 
blocking (preventing translation by binding to mRNAs at or near the translation start 
size) mechanisms to confer short term knockdown lasting up to several days 
(Nasevicius and Ekker, 2000; Pickart and Klee, 2014; Vacaru et al., 2014).  Zebrafish 
embryos can be visualized and recorded in vivo via microscopy tools. Transgenic 
zebrafish lines are often tagged with a fluorophore allowing for in vivo observation and 
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recording of cell population housing the protein of interest.  Whole embryo staining is 
an in vitro tool used to observe spatial and temporal localization of molecular targets.  
Zebrafish whole mount in situ hybridization (ISH) is widely used to visualize spatial 
and temporal expression of RNA populations in fixed staged whole embryos (Thisse 
and Thisse, 2008).  Cartilage and bone development can also be assessed and visualized 
using in vitro staining techniques (Walker and Kimmel, 2007).  This thesis details the 
investigation of the functional requirement for RBM24 in cardiovascular and somite 
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Gastrulation 5.5 7 15-16 
Heart fields 13 7 18 
Heart trough 19  (cone) 8 21-23 
Heart tube 22 8.5 24 
Looping 24-48 8.5-10.25 24-25 
Myocardial contraction 22 8.5 24 
 







1.8 Figures:  Chapter 1 
 
Figure 1-1. Rbm24 is expressed in the heart early in cardiogenesis 
 
Rbm24 is expressed in the cardiac crescent of E7.5 embryos (arrowhead). At E.8.5 
expression is in the HT, OFT, BA, and IFT.  AT E9.5 expression persists in the heart 
and is additionally detected in the somites.  HT, heart tube; H, heart; OFT, out flow 
tract; IFT, inflow tract; BA, branchial arches; S, somites; E7.5-9.5; embryonic days 7.5-





Figure 1-2. Schematic of zebrafish cardiac development 
 
 
At 5 hpf atrial and ventricular cardiac progenitor cells become visible and organized 
(A).  Cardiogenic differentiation is initiated in the future ventricle myocardial cells by 
the expression of cardiac myosins (purple) at the 12-somite stage (B). During mid- and 
late-somite stages, the myocardial tissue expands by continuous cardiogenic 
differentiation of future atrial myocytes (orange), while endocardial cells (light green) 
begin populating (C). When the bilateral heart fields fuse at the mid-line, they form a 
cardiac disc structure with the endocardial cells within the hole at the centre, ventricular 
myocytes at the circumference and atrial myocytes at the periphery of the disc (D). 
Cardiac morphogenesis transforms the cardiac disc into a cardiac tube. The 
 15 
endocardium forms the inner lining of the myocardial tube. At 28 hpf, the linear heart 
tube has formed (E).  At 36 hpf,  the AV canal is first visible and cardiac looping has 
started with cardiogenic differentiation continuing by adding new cardiomyocytes to 
this region (purple gradient) (F). At 48 hpf loopint is completed and the heart tube has 
formed an S-shaped loop (G). Ellipsoid extra-cardiac pro-epicardial cells (brown), AV 
canal (yellow), pacemaker cells (dark green).  Adapted from (Bakkers, 2011). 
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Figure 1-3. Somite development in zebrafish 
 
Adapted from (Stickney et al., 2000). 
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Figure 1-4. Notch segmentation clock 
 
Comparison by two-color in situ hybridization of segmental and cyclic genes in the 
presomitic mesoderm in embryos at 14 hpf (10 somites) is shown in dorsal view after 
flat mounting with anterior upwards (G-J). In all panels, her7 has been developed in 
blue/black.  Domains of cyclic gene expression at stages III, I+ and II, according to the 
nomenclature of Jiang et al. (Jiang et al., 2000); in G-J. The co-expression of myod (G), 
her1 (H), dlc (I) and dld (J) are shown in red. (K) Diagram of the relative positions of 
the domains of cyclic gene expression (her7, black; her1, green; dlc, red; dld, blue) to 
each other within a combined domain moving anteriorly (arrow) in the PSM. (L) The 
gene expression cycle experienced multiple times by individual cells in the PSM, 
inferred from the spatial relationships (K).  Adapted from (Oates and Ho, 2002)
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CHAPTER 2 
 rbm24a & rbm24b ARE EXPRESSED DURING EMBRYOGENESIS AND 




In this chapter we investigate the putative role of RBM24 in cardiac 
development.  The following study details the identification of two RBM24 zebrafish 
homologs (termed rbm24a and rbm24b), and demonstration that their spatial expression 
is consistent with what was previously observations in mouse (Miller et al., 2008). We 
use rbm24a and rbm24b translation blocking morpholino antisense oligonucleotides in 
the early embryo and demonstrate that each zebrafish rbm24 homolog has a key but 
unequal role to play in cardiac development.  Additionally, we demonstrate a role for 
rbm24a and rbm24b in normal vascular development. Our findings show the 
requirement for rbm24a and rbm24b in cardiac development and vasculogenesis with a 
more pronounced role for rbm24a, and an additional putative role for rbm24a in 
angiogenesis.  
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2.2 Results  
 
2.2.1 Phylogenetic comparative analysis establishes two rbm24 homologs in 
zebrafish 
We recently reported the identification of Rbm24 as one of a number of novel 
transcripts discretely expressed in the earliest stages of cardiac development in the 
mouse embryo (Miller et al., 2008).  To facilitate determination of the biological 
requirement for this gene during vertebrate embryonic development, we first set out to 
identify the homologs gene/s in zebrafish.  In the transition between assembly Zv8 and 
Zv9 of the zebrafish genome, first one and then a second putative rbm24 homolog was 
identified. The current assembly (Zv9) identifies a protein coding gene as rbm24a 
residing on chromosome 19 and also a novel annotation of a putative rbm24b protein 
coding gene residing on chromosome 16. To confirm the validity of these most recent 
changes to the genome annotation we compared these findings to our own comparative 
genomic analyses. 
The first annotated rbm24a gene encodes a protein that displays strong 
similarity to the mouse Rbm24 (E-value = 3e-90; 188/237 (79%) amino acids). Using 
the mouse Rbm24 as a blastp query to search the NCBI RefSeq database of D. rerio 
proteins we detected strong similarity (E-value = 5e-61; 103/116 (88%)) to a 
hypothetical protein LOC562236 encoded by a gene (zgc:136803) on chromosome 16 
(Zv8).  This protein is now termed rbm24b in Zv9. The identification of these genes as 
rbm24 homologs is further supported by the identification of a pair of annotated rbm24 
paralogs in both the medaka (Oryzias latipes; chr. 11, 16) and pufferfish 
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(Tetraodon nigroviridis; chr. 21 and 8) genomes.  Zebrafish chromosome 19, where 
rbm24a resides, shares a common evolutionary origin with O. latipes chromosome 11 
and T. nigroviridis chromosome 21 (Kasahara et al., 2007).  Similarly, chromosomes 16 
and 8 in O. latipes and T. nigroviridis, respectively, map to the rbm24b region of 
chromosome 16 in D. rerio. 
 
2.2.2 rbm24a and rbm24b display cardiovascular expression during embryogenesis 
The spatial and temporal expression of both rbm24 homologs was determined 
using RNA in situ hybridization (ISH) (Figure 2-1). Both rbm24 homologs show 
cardiac expression early in development.  At 15.5 hpf we detected rbm24a but not 
rbm24b expression in myocardial precursor cells (Figure 2-1 B and C).  By 24 hpf both 
rbm24a and rbm24b expression was detected in the forming heart (Figure 2-1 E and F).  
Expression of rbm24a was also detected in the lens of the eye. By 48 hpf, and 
continuing through 72 hpf, rbm24a and rbm24b exhibit broad expression throughout the 
heart, although expression of rbm24a was higher in the atrium than the ventricle. By 
contrast expression of rbm24b appeared uniformly expressed in both heart chambers 
(Figure 2-1 I and L).  These data are consistent with cardiac expression of the mouse 
Rbm24 homolog, and suggest incompletely overlapping requirements for rbm24a and 
rbm24b during zebrafish cardiac development. 
By 72 hpf both rbm24a and rbm24b show incompletely overlapping vascular 
expression in addition to cardiac expression.  rbm24a is expressed in the DA and 
intestinal vasculature (Albers et al.) while rbm24b is expressed in the PCV as well as 
the IV (Figure 2-1 N and O).  The early expression of both rbm24a and rbm24b in both 
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the heart and vasculature suggests potentially important roles in cardiogenesis and 
vasculogenesis.   
 
2.2.3 rbm24a and rbm24b are required for normal cardiac development 
To determine the functional role of the rbm24 homologs in cardiac and vascular 
development, translation blocking MOs were designed against the 5’ UTR of each 
transcript.  The effects of gene knockdown was assessed for each homolog individually 
post microinjection of either MO into zebrafish embryos at the 1-2 cell stage.  Titration 
experiments were conducted to determine MO quantities sufficient to induce a 
consistent phenotype in a majority of embryos injected (Figure 2-2).  Injection of 5 ng 
of rbm24aMO or 8 ng rbm24bMO resulted in a robust cardiac phenotype for a 
significant number of injected embryos at 48 hpf (64/67 and 59/62 respectively) (Table 
2-1), compared to uninjected embryos (Figure 2-3 A, B and D).  During cardiogenesis 
the heart tubes of all affected morphant embryos failed to correctly loop, remaining 
linear but with distinct ventricular and atrial chambers (Figure 2-3).  Affected embryos 
also exhibited reduced blood circulation, which led to cardiac edema in all cases by 48 
hpf and continually worsened as development progressed (Figure 2-3).  A subset of 
rbm24aMO treated embryos (6/64) displayed an even more severe phenotype, lacking a 
distinct heart tube and exhibiting a beating focus of periodically contracting cells.  This 
poorly organized cardiac structure was located ventral to the embryo between the 
embryo and the yolk suggesting a defect in the migration and organization of the 
cardiac fated cells.  Similarly reduction of rbm24a or rbm24b expression using splice 
blocking morpholinos, designed against the second intron/exon boundary, also resulted 
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in cardiac looping defects and cardiac edema in a majority of embryos (92.7% and 
54.4% respectively) (Figure 2-4).  Knockdown efficiency was evaluated by RT-PCR for 
embryos displaying cardiac looping defects and cardiac edema after injection with 
splice blocking morpholino.  Both rbm24a and rbm24b transcript levels were 
significantly reduced to 42.80% +/- 3.35, P < 6.5 x 10
-4
 and 40.27% +/- 3.19, P < 4.4 x 
10
-5
 of transcript levels in respective uninjected controls (Table 2-2).  We used 
translation blocking MO in all subsequent MO-based experiments due to their greater 
efficacy. 
To confirm the phenotype observed in the rbm24 morphants was not due to non-
specific morpholino toxicity, embryos were co-injected with p53 morpholino and 
rbm24aMO or rbm24bMO (Methods).  The cardiac phenotypes remained unchanged in 
the presence of the p53 morpholino (Figure 2-5).  We then performed phenotype rescue 
for both rbm24 morphants to determine the sequence specificity of the observed 
morphant phenotypes.  We generated full length capped poly-A RNA transcripts for 
each homolog and co-injected each along with the respective rbm24MO, directed 
against the 5’UTR not present in the in vitro transcribed RNA.  Rescue for rbm24aMO 
was achieved with 800 pg of RNA (36/45) while 50 pg of RNA was sufficient for 
rbm24bMO rescue (35/47).  For both homologs rescue resulted in properly looped 
hearts, normal systemic circulation and an absence of cardiac edema and by 72 hpf and 
continuing to 96 hpf (Figure 2-3 F, H, J, K, M and P).  Taken collectively, these data 
suggest the phenotype seen with each rbm24MO is a specific result of reduction in gene 
expression and support the inference from ISH expression data that both rbm24 
homologs are required for normal cardiac development. 
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2.2.4 Depletion of Rbm24a and Rbm24b compromise cardiac myocardium 
development  
To better evaluate the impact to the heart of reducing rbm24a or rbm24b we 
assayed the expression of several key myocardial transcripts by ISH, including myosin 
light polypeptide 7, myl7 (heart), myosin heavy polypeptide 6, myh6 (atrium) and 
ventricular myosin heavy chain, vmhc (ventricle).  Expression of each marker was 
evaluated in control (uninjected), rbm24aMO and rbm24bMO injected embryos fixed at 
72 hpf at which point the zebrafish heart is normally, looped, fully developed and 
functioning, allowing us to comment in greater detail on the structural deficits 
contributing to the gross morphological morphant phenotypes.  When examining the 
entire heart, both rbm24a and rbm24b morphant embryos exhibit strong myl7 
expression levels comparable to that of controls albeit within an unlooped heart tube. 
The hearts of controls by contrast are appropriately looped (Figure 2-6 A – F). 
Additionally in rbm24a morphants defects of the presumptive atrium of the forming 
heart tube appear more severe than in the ventricular portion (Figure 2-6 C and D).  By 
contrast organization of the developing ventricle and atrium in rbm24bMO embryos 
appears equally compromised (Figure 2-6 E and F).  Expression of the atrial marker 
myh6 for both rbm24 morphants appears qualitatively similar to levels in uninjected 
controls.  Presumptive atria of rbm24a morphant heart tubes appear linear and 
truncated, while to rbm24b morphants also have linear longer heart tubes, both 
contrasting with the looped atrium observed in uninjected controls (Figure 2-6 G – L).   
These data are consistent with the observations that rbm24a expression was higher in 
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the atrium than the ventricle by 72 hpf, contrasting with the more uniform expression 
observed for rbm24b across both heart chambers (Figure 2-1).   
Both rbm24 morphant conditions exhibited a near abrogation of the levels of the 
ventricular marker vmhc compared to strong expression in uninjected controls (Figure 
2-6 M – R).  In rbm24aMO morphants expression of vmhc was faint but with 
expression clearly bounded to the heart tube with a clear ventricular portion; however, 
the expression uncharacteristically extended beyond the ventricular portion into the 
presumptive atrium of the heart tube (Figure 2-6 O and P).  For rbm24b morphants 
vmhc expression was very diffuse and failed to clearly mark a ventricular boundary.  
These findings for vmhc expression were unexpected; both in the reduction of total 
expression seen for both rbm24 morphants and the apparent stronger severity of the 
ventricular phenotype compared to the atrial phenotype for both rbm24 morphants.  
Taken together the expression of these markers highlight the differential spatial impact 
of each rbm24 homolog in heart structure development of the myocardium, and is 
consistent with our previous gross morphological observations.  These data indicate an 
incompletely overlapping role for rbm24a and rbm24b in heart tube formation and 
subsequent heart looping.   
 
2.2.5 Edema in rbm24 morphant embryos may have multiple origins 
The observed cardiac edema may result from reduced circulation as a 
consequence of defects in heart structure, heart rate, aberrant vasculature or 
combinations of these factors. Given the observed structural defects, we additionally 
assayed heart rate as a potential contributor to cardiac edema in the rbm24aMO and 
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rbm24bMO injected embryos (Baker et al., 1997).  Heart rate counts were determined 
for uninjected, rbm24aMO and rbm24bMO injected embryos (n = 50) at 48, 72 and 96 
hpf.  At 48 hpf both rbm24a and rbm24b morphants displayed significantly lower heart 
rate compared to uninjected controls (P < 0.0002) (Figure 2-7). Heart rates in 
rbm24aMO injected embryos remain significantly lower than uninjected controls at 72 
hpf and 96 hpf.  By contrast the heart rate of rbm24bMO injected embryos recovered 
such that it did not differ significantly from uninjected controls at 72 hpf and 96 hpf (P 
> 0.12) despite their continued structural anomalies.  These data demonstrate cardiac 
edema is not ameliorated in rbm24b morphants despite heart rates increasing to normal 
levels, suggesting the role of other factors must be considered as contributing to 
compromised circulation.  Although defects in structure and rates of contraction may 
contribute to compromised circulatory function, we posit that vascular disruption likely 
also plays a role in the resulting edema. 
 
2.2.6 rbm24a and rbm24b are required for normal vasculogenesis with a potential 
role in early angiogenesis 
To determine the functional role of rbm24a and rbm24b in vascular 
development we also undertook MO-based analyses of each homolog in the TG(kdrl:G-
RCFP) transgenic zebrafish reporter line which fluorescently marks all endothelial cells 
highlighting the forming cardiovascular structures (Cross et al., 2003).  Embryos were 
examined for vascular expression, after injection of rbm24aMO or rbm24bMO as 
described above, after heart formation and completion of vasculogenesis at 48 and 72 
hpf (Figure 2-8).  As per our earlier experiments, morphant embryos for both genes 
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exhibit endocardial cardiac edema and a lack of heart looping displaying little to no 
circulation with 30/31 and 45/50 embryos displaying cardiac defects for rbm24a and 
rbm24b morphants respectively (Figure 2-8 D – F and M – O).  Additionally, all 
rbm24a and rbm24b morphant embryos display a reduction in total trunk vasculature 
and vascular organization in 100% of the embryos (Figure 2-8 G – I and P – R); 
however vasculogenic and angiogenic vessels are disrupted to differing degrees.   At 48 
hpf rbm24a morphants posses a clearly present PCV appearing thicker than normal with 
no detectable DA or CV (Figure 2-8 H).   Angiogenesis is severely disrupted in these 
embryos with unpaired stunted dysmorphic Se also appearing thicker extending only to 
the midline of the embryo and thus a complete lack of DLAVs.  By contrast the rbm24b 
morphant at 48 hpf shows little to no disruption of the DA, a visible but malformed CV 
and no detectable PCV (Figure 2-8 I).  Unlike rbm24a morphants, rbm24b morphants 
have less disruption of angiogenesis.   Se in rbm24b morphants display pairing at the 
posterior end of the embryo and extend dorsally the length of the embryo forming one 
DLAV; however, all these vessels are structurally dysmorphic.  Both rbm24a and 
rbm24b vascular morphant phenotypes become progressively more severe between 48 
hpf and 72 hpf. Vessels are less well organized and the number of vessels present is 
reduced, with no evidence of IV (Figure 2-8 J – L and P – R).  Of the morphant 
embryos displaying cardiac defects rbm24a and rbm24b morphants segregated into 
different classes of vascular defects, with 31/31 rbm24a morphants analyzed possessing 
disorganized trunk vasculature where Se do not extend the entire dorsal length of the 
embryo and the DA and CV are undetectable; and 50/50 rbm24b morphants had 
disorganized trunk vasculature where the Se formed DLAV and yet the PV was 
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undetectable (Figure 2-8 S and T).  These data correlate with respective primary 
vascular expression locations of rbm24a of DA and rbm24b of PCV and both 
displaying expression in the IV (Figure 2-1 G and H).  When expression of rbm24a or 
rbm24b is compromised formation of the vessels required for the initial circulation loop 
is similarly compromised, likely contributing significantly to the observed cardiac 
edema in morphant embryos.  These findings indicate the endocardium is also 
compromised as a result of rbm24 knockdown and also suggests that both rbm24a and 
rbm24b are independently necessary for normal early vascular development and support 
a putative role for rbm24a in angiogenesis. 
 
2.2.7 rbm24a and rbm24b exhibit incompletely overlapping functions in zebrafish 
development 
To determine whether rbm24a and rbm24b interact genetically in the developing 
zebrafish embryo, we injected low doses of both rbm24a and rbm24b MOs into the 
same embryo.  Although each MO dosage amount was too low (2.5 ng and 4 ng 
respectively) to elicit a strong consistent phenotype alone as evidenced by titration 
experiments (Figure 2-2), a much more severe phenotype resulted in the morphants 
receiving both MOs in concert (Figure 2-9).  The double morphants displayed greater 
cardiac edema at 24 hpf than either morphant alone (Figure 2-9 A – D).   By 48 hpf, the 
double morphants also displayed very little cardiac organization, with most (73/93) 
failing to form any heart tube structure. No double morphants displayed any circulation 
(Figure 2-9 E– H).  This severe and distinctive phenotype exceeds that observed for 
either MO when assayed independently, even at the higher concentrations that yield 
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consistent cardiac defects (5 ng of rbm24aMO or 8 ng rbm24bMO). These data support 






We previously identified Rbm24 as a novel gene expressed during mouse 
cardiac development (Miller et al., 2008). Due to its tightly restricted and persistent 
expression from formation of the cardiac crescent onwards and later in forming 
vasculature we posited it to be a key player in cardiogenesis with additional roles in 
vasculogenesis and angiogenesis. 
To investigate the role of RBM24 in cardiac development, we identified its 
zebrafish homologs, rbm24a and rbm24b, and functionally evaluated them during 
zebrafish embryogenesis. Consistent with our underlying hypothesis, reduction in 
expression of either homolog through injection of morpholino antisense 
oligonucleotides resulted in cardiogenic defects including cardiac looping and reduced 
circulation, leading to increasing pericardial edema over time. Additionally, morphant 
embryos for either homolog displayed incompletely overlapping defects in the forming 
vasculature of the DA, PCV and CV (Albers et al.). Vasculogenesis and early 
angiogenesis in the trunk were similarly compromised in rbm24 morphant embryos.  
Subsequent vascular maintenance was impaired in both rbm24 morphants with 
substantial vessel degradation noted at 72 hpf. 
Taken collectively, our functional data support the hypothesis that rbm24a and 
rbm24b are key developmental cardiac genes with unequal roles in cardiovascular 
formation, with each essential for normal cardiovascular development.  The results of 
these investigations present rbm24a and rbm24b as developmental genes of interest for 




2.4.1 Zebrafish maintenance 
Adult AB zebrafish were maintained in system water according to standard methods 
(Westerfield, 1995).  Embryos were obtained from natural mating of adult fish.  All 
experiments were in accordance with ethical permits by Johns Hopkins Animal Care 
and Use Committee under protocol number FI10M369. 
 
2.4.2 Bioinformatic identification of zebrafish rbm24 homologs 
We used the amino acid sequence of the protein encoded by the mouse Rbm24 gene to 
perform a blastp query searching the NCBI RefSeq database of D. rerio proteins from 
the Zv8 2008 genome assembly. Two genes were identified (rbm24 and zgc:136803) 
which encode proteins displaying strong similarity to the mouse Rbm24 protein (E-
value = 5e-61; 103/116 (88%) and E-value  = 3e-90; 188/237 (79%), respectively).  As 
of the Zv9 2010 D. rerio genome assembly NCBI RefSeq now annotates the two genes 
we previously identified as two rbm24 paralogs with protein coding transcripts: rbm24a  
on chromosome 19 (RefSeq ID: NM_212865) and rbm24b on chromosome 16 (RefSeq 
ID: NM_001039925). 
 
2.4.3 Nucleic Acid in situ hybridization 
Total RNA was isolated from whole zebrafish embryos at 24 hpf using TRIzol Reagent 
and total cDNA was generated with oligo-dT using the SuperScript III First-Strand 
Synthesis Kit (Invitrogen).  Riboprobes for rbm24a, rbm24b, myl7, myh6, and vmhc 
were generated by PCR amplification of embryo cDNA.  PCR fragments were TOPO 
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cloned into PCRII vector (TA Cloning Kit Dual Promoter with pCRII vector, 
Invitrogen) and transformed into TOP 10 Cells (Invitrogen).  Colonies were mini 
cultured and plasmid DNA was harvested using the QIAprep Spin Miniprep Kit 
(Qiagen) Digoxygenin-labeled riboprobes were synthesized from 1 g plasmid DNA 
using Sp6 and T7 RNA Polymerase (DIG RNA Labeling Kit SP6/T7, Roche), and 
purified (SigmaSpin Colums, Sigma).  Embryos for in situ hybridization at 48 hpf and 
older were treated with 0.003% PTU beginning at 48 hpf to reduce pigmentation.  
Embryos were fixed in 4% paraformaldehyde in PBS overnight at 4°C at 15.5 hpf, 24 
hpf, 48 hpf, and 72 hpf; and in situ hybridization was performed as previously described 
(Miller-Bertoglio et al., 1997). 
 
2.4.4 Morpholino design and injection 
Antisense morpholinos for rbm24a and rbm24b were designed and provided by Gene 
Tools, LLC.  The rbm24a translation blocking morpholino (5’-
TGCATCCTCACGAAACGCTCAAGTG-3’) and the rbm24b translation blocking 
morpholino (5’-AAATAAACTCCTTGCTCCTTGAAGG-3’) were designed to 
hybridize to the 5’ UTR immediately upstream of the translational start site.  
Morpholinos were diluted with dH2O to 20 ng / nL and titration experiments were 
conducted at 1, 2, 5 and 10 ng rbm24aMO and 1, 2.5, 5, 7 and 9 ng rbm24bMO to 
determine an effective dose (n = 100 embryos per concentration).  Experimental 
concentrations of 5 ng rbm24aMO or 8 ng rbm24bMO were selected and injected into 
the yolks of 1-2 cell fertilized embryos (n = 75).  Double knockdown experiments were 
conducted with co-injection of 2.5 ng rbm24a and 4 ng rbm24b translation blocking 
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MO into embryos and compared to embryos injected with these amounts of either MO 
alone.   The rbm24a splice blocking MO (5’ CGTTATTTGAGATGCCTGACTGTT 3’) 
and the rbm24b splice blocking MO (5’ TATTTTGACGTTATTTACCTGGCTG 3’) 
were designed to hybridize to the boundary of the second exon and second intron of the 
transcript and injected at 7.5 ng and 9 ng respectively.  Antisense p53 MO (5’-
GCGCCATTGCTTTGCAAGAATTG-3’) previously published (Langheinrich et al., 
2002) was purchased from Gene Tools, LLC and 1 ng was injected into 1-2 cell stage 
fertilized embryos both with and without each rbm24 translation blocking MO (n = 50) 
(Robu et al., 2007).  Embryos were analyzed for cardiac and vascular phenotypes at 48, 
72 and 96 hpf. 
 
2.4.5 RT-PCR to determine transcript knock down efficiency 
Total RNA was isolated using TRIzol Reagent (Invitrogen) from whole morphant 
zebrafish embryos at 24 hpf after injection of either 7.5 ng rbm24a or 9 ng rbm24b 
splice blocking MO.  Total cDNA was generated with oligo-dT using SuperScript III 
First-Strand Synthesis (Invitrogen).  RT-PCR was carried out via the standard curve 
method on a Bio-Rad DNA Engine Opticon 2 Real-Time Detection System with 
primers specific to the correctly spliced transcripts at 100 ng input cDNA.  Uninjected 
24 hpf embryo cDNA was used to generate a standard curve and cDNA from uninjected 
experimental control embryos was assayed at 100 ng cDNA as the standard for 100% 
expression. All reactions were run in triplicate at 25µL volumes using Power Sybr 
Green PCR Master Mix (1x final) (Applied Biosystems), primers at final concentration 
0.08 µM each.  Significance of expression reduction was determined using the students 
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t-test statistic comparing transcript levels of rbm24a or rbm24b in uninjected controls to 
that measured cDNA from their respective morphants.  
 
2.4.6 rbm24 MO phenotype rescue 
Total RNA was isolated from whole zebrafish embryos 24 hpf using TRIzol Reagent 
(Invitrogen) and total cDNA was generated with oligo-dT using SuperScript III First-
Strand Synthesis (Invitrogen).  Full length rbm24a and rbm24b cDNA were PCR 
amplified and cloned into the pCR8 gateway vector (pCR8⁄GW⁄TOPO TA Cloning Kit, 
Invitrogen) before being cloned into the pCSDEST destination vector (kindly provided 
by the lab of Nathan Lawson, UMass Med School).  Full length sense capped Poly-A 
RNA was generated for rbm24a and rbm24b with the mMESSAGE mMACHINE kit 
(Ambion) and quantified with a NanoDrop 1000.  Full length RNA was co-injected into 
1-2 cell embryos with rbm24aMO or rbm24bMO at titrating levels and evaluated for 
phenotype rescue at 48, 72 and 96 hpf.  Rescue was confirmed with 800 pg rbm24a 
RNA and 50 pg rbm24b RNA. 
 
2.4.7 Sequence analysis 
Genomic DNA from two patients and an unaffected family member were included 
(Wessels et al., 2008). Direct sequencing of part of the promoter region (1031 bp), all 
exons plus exon-intron boundaries and a putative regulatory element in intron 3 (1164 
bp) of the RBM24 gene was undertaken. Primers were designed to cover all four exons 
representing the “canonical” sequence (ENST00000379052, transcript length 2,458 bp 
and 236 aa, www.ensembl.org). PCR primers were designed by Primer3 software 
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(http://frodo.wi.mit.edu/cgi-bin/primer3/primer3.cgi) and are available on request.  
Amplified PCR products were purified and sequenced using BigDye Terminator 
chemistry v3.1 on an ABI Prism 3130xl genetic analyzer (Applied Biosystems). 
Biomedical research involving human subjects has been performed according to the 
principles of the Helsinki's Declaration. Written informed consents were obtained from 
the patients and relatives involved in the research.  Genomic DNA was taken from 
patients as per standard care and therefore ethical approval was not required. 
 
2.4.8 Heart Rate counts 
Heart rates (beats per minute) were counted for uninjected, rbm24aMO and rbm24bMO 
injected embryos displaying the morphant phenotype at 48, 72 and 96 hpf.  50 embryos 
were analyzed per condition per time point.  Average heart rates with standard error 
were plotted and significant heart rate deviation of morphants compared to uninjected 
controls was determined using the students t-test.   
 
2.4.9 Fluorescent vascular imaging 
The transgenic zebrafish line TG(kdrl:G-RCFP) generated by Cross and colleagues 
(Cross et al., 2003) was used for vascular expression. Adult fish and embryos were 
maintained as described (Westerfield, 1995).  Embryos were injected with either 5 ng 
rbm24aMO or 8 ng rbm24bMO at the 1-2 cell stage and analyzed at 48 and 72 hpf for 
G-RCFP expression via fluorescence microscopy.  
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2.5 Tables:  Chapter 2 
 











rbm24aMO 5 ng 67 








+ 800 pg 
RNA 
45 
9   
(20 %) 
9   
(20 %) 
0 
rbm24bMO 8 ng 62 
59   
(95.2 %) 





+ 50 pg 
RNA 
47 
12   
(25.5 %) 






Table 2-2.  Cardiac phenotypes displayed upon knockdown of rbm24a or rbm24b 










rbm24aMO sb 7.5 ng 96 
89   
(92.7 %) 
89   
(92.7 %) 
0 
rbm24bMO sb 9 ng 79 
43   
(54.4 %) 








2.6 Figures: Chapter 2 
Figure 2-1. rbm24a and rbm24b display cardiovascular expression during 
embryogenesis.   
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Expression of rbm24 transcripts was evaluated in uninjected embryos fixed at 15.5, 24, 
48 and 72 hpf. Live embryos 15.5 hpf with area of interest for rbm24 in situ boxed in 
white (A).  Lateral heart views of rbm24a and rbm24b in situs on uninjected 15.5 hpf 
embryos showed expression linearly organized myocardial precursor cells for rbm24a 
(black box, B) but not rbm24b (C).  Live embryos 24 hpf with area of interest for rbm24 
in situ boxed in white (D).  Lateral heart views of rbm24a and rbm24b in situs showed 
expression in the developing heart tube at 24 hpf (black box, E, F) with lens expression 
for rbm24a alone.  48 hpf live embryo showing the heart boxed in white (G).  Lateral 
zoom of the heart showed rbm24a and rbm24b were expressed in the ventricle (v) and 
atrium (a) of the looped heart at 48 hpf (H, I).  Live 72 hpf embryos with the heart 
boxed in white (J).  Expression of both rbm24 transcripts was detected in the heart at 72 
hpf (K, L).  Live image of a 72 hpf embryo with the area of interest for vascular 
expression boxed in white (M).  Expression of both rbm24 transcripts was detected in 
the trunk vasculature with differing expression patterns.  rbm24a shows arterial 
expression in the DA (N) while rbm24b shows venous expression in the PCV (O) with 






Figure 2-2.  Translation Blocking MO titrations.   
 
Quantitative representation of percentage of embryos displaying cardiac phenotypes 
achieved from MO titrations.  rbm24aMO 1, 2, 5 and 10 ng injected (A). rbm24bMO 1, 
2.5, 5, 7 and 9 ng (B).  Normal, looped beating heart with no cardiac edema; Class I, 
looped beating heart with cardiac edema; Class II, unlooped beating heart tube with 
cardiac edema; Class III,  beating heart cell mass with cardiac edema; Dead, extreme 
cell death and degradation of embryo.  n = 100 embryos per concentration. 
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Figure 2-3.  rbm24a and rbm24b are required for normal cardiac development.   
 
Translation blocking morpholinos complementary to rbm24a (5 ng) or rbm24b (8 ng) 
were injected into 1-2 cell stage zebrafish embryos and the resulting phenotypes were 
evaluated compared to uninjected controls at 48 hpf (A, B, D), 72 hpf (F,G,I), and 96 
hpf (K, L, O).  Lateral heart views are shown with a dotted outline around the heart 
chambers.  Both morphant embryo conditions exhibited cardiac looping defects and 
edema at all stages.  Heart chambers are shown with a dotted outline with chambers 
denoted: v, ventricle; a, atrium; black arrows, cardiac edema.  Phenotype rescue was 
achieved for each rbm24 via co-injection of each respective full length capped poly-A 
RNA transcript (rbm24a 800 pg , rbm24b 50 pg) along with the respective 
complementary translation blocking morpholino into 1-2 cell stage embryos where 800 
pg rbm24a (C, H, M) or 50 pg rbm24b (E, J, P) achieved rescue.  Rescued embryos 
posses looped hearts absent of edema.  
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Figure 2-4.  rbm24a and rbm24b splice blocked morphants display cardiac 
defects.   
 
Injection of 7.5 ng of rbm24a splice blocking morpholino results in a substantial 
reduction of full-length transcript (A).  Injection of 9 ng of rbm24b splice blocking 
morpholino results in aberrant splicing of the transcript.  There is a reduction of full-
length transcript 250 bp fragment and appearance of trace amounts of the shortened 
frameshift fragment 164 bp and shortened in-frame transcript 109 bp (B).  RT-PCR 
measurement of transcript levels show both rbm24a (42.80% +/- 3.35, P < 6.5 x 10
-4
) 
and rbm24b (40.27 +/- 3.19, P < 4.4 x 10
-5
) morphants have significant reduction of 
transcript levels compared to uninjected controls (C) Error bars are standard deviation,  
*** P < 0.001.   
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Figure 2-5.  p53 MO co-injection does not alter rbm24a and rbm24 morphant 
phenotypes.   
 
Phenotypes were evaluated for embryos post injection rbm24a MO (5 ng) or rbm24b 
MO (8 ng) alone or in conjunction with p53 MO (1 ng) phenotypes were compared at 
48, 72 & 96 hpf.  Lateral heart views are shown with a dotted outline around embryo 
heart chambers.  No cardiac phenotype is detected for p53 MO embryos compared to 
uninjected controls at any time point (A-B, G, H, M, N).  At all time points rbm24a 
morphants maintain unlooped hearts and display cardiac edema in the presence of p53 
MO (C, D, I, J, O, P).  Morphant phenotype was also maintained between rbm24b 
morphants in the presence of p53 MO (E, F, K, L, Q, R). v, ventricle; a, atrium; black 
arrows, cardiac edema. 
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Figure 2-6.  Depletion of rbm24a and rbm24b compromise cardiac myocardial 
development.   
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The expression patterns of cardiac markers were analyzed in rbm24 morphants and 
uninjected controls at 72 hpf.  Ventral and lateral images of the heart are shown with a 
dotted line marking the boundary between heart chambers.  By myl7 expression of the 
entire heart, uninjected controls possess looped hearts with defined ventricle and atrium 
chambers (A, B) in contrast to unlooped hearts for both rbm24 morphants.  rbm24a 
morphants displayed linear presumptive ventricle and an incompletely formed 
presumptive atrium (C, D).  rbm24b morphants displayed a linear presumptive atria and 
ventricle (E, F).  myh6 marking the atrium displayed a looped atrium in controls (G, H) 
with linear atrium in rbm24a (I, J), and rbm24b morphants (K, L).  vmhc expression 
demarks looped ventricles in controls (M, N). rbm24a morphants displayed little 
expression bound to an unlooped heart tube where expression extends to the 
presumptive atrium (O, P).  Almost no vmhc expression is detectable in rbm24b 
morphants (Q, R). v, ventricle region; double arrow, ventricular expression a, atrium 
region; solid black arrow, atrial expression. 
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Figure 2-7.  Slow heart rate may contribute to cardiac edema in rbm24 morphants.   
 
Heart rates were determined for uninjected control, rbm24a and rbm24b morphant 
embryos at 48, 72 & 96 hpf and significance was ascribed from a t-test statistic.  50 
embryos were examined for each condition at each time point.  At all time-points the 
heart rate of rbm24a morphants was significantly lower than controls where P < 2x10
-5
.  
At 48 hpf rbm24b morphants had significantly lower heart rates than controls (P = 
1x10
-32
).  The heart rates for rbm24b morphants then rose to rates not different from 
controls by 72 hpf and 96 hpf (P > 0.12) while maintaining the features of the morphant 
phenotype.  Error bars here are standard error.   *** P < 0.001. 
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Figure 2-8.  Reduction of rbm24a or rbm24b results in aberrant vasculature and 
a lack of vascular maintenance.   
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TG(kdrl:G-RCFP) zebrafish line was used to asses the impact of rbm24 depletion on 
vasculature at 48 hpf and 72 hpf.  Lateral views are shown for whole embryo, heart and 
trunk with a dotted outline indicating heart chamber boundaries.  Uninjected controls at 
all time-points display looped hearts and properly developed vasculature.  (A, D, G, J, 
M, P).  48 hpf rbm24a morphants possess unlooped hearts but display only the PCV and 
stunted disorganized Se (B, E, H).  48 hpf rbm24b morphants possess unlooped hearts, 
and only the DA and CV are visible with disorganized Se (C, F, I).  By 72 hpf there was 
increased vascular disorganization and degeneration and a lack of heart looping and in 
both rbm24 morphants (K, N, L, O, Q, R).  Cardiac morphant phenotypes are displayed 
quantitatively as percentages; Normal, looped beating heart with no cardiac edema; 
Class I, looped beating heart with cardiac edema. Class II, unlooped beating heart tube 
with cardiac edema, Class III,  beating heart cell mass with cardiac edema; Dead, 
extreme cell death and degradation of embryo (S).  Morphant vascular phenotype 
classes; Class A, disorganized trunk vasculature with formed DLAV; Class B, 
disorganized trunk vasculature with truncated Se and no DLAV; Class C, no 
discernable PCV; Class D, no discernable DA or CV (T).  v, ventricle; a, atrium;  DA, 
dorsal aorta; CV, caudal vein; PCV, posterior caudal vein; Se, intersegmental vessels, 
DLAV, dorsal longitudinal anastomotic vessels; IV, intestinal vasculature.   
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Figure 2-9. Double rbm24a and rbm24b morphants display more severe cardiac 
defects.   
 
Morpholinos directed to each rbm24 homolog were injected individually and in tandem 
into zebrafish embryos and assessed at 24 hpf and 48 hpf compared to uninjected 
embryo hearts (A and E).  Individual morpholino injections were titrated to a low dose 
for both rbm24a, 2.5 ng (B and F) and rbm24b, 4ng (C and G). Embryos receiving low 
doses of both rbm24a and rbm24b morpholinos resulted in more severe phenotype than 




 Rbm24a & Rbm24b ARE ESSENTIAL FOR  
SOMITE AND CRANIOFACIAL DEVELOPMENT 
 
3.1 Preface 
We initially identified Rbm24 in a screen for early cardiac genes and 
demonstrated it to be expressed at multiple time points during mouse cardiogenesis as 
well as in the somites (9.5 dpc) (Miller et al., 2008). Our subsequent cardiovascular-
focused studies in zebrafish determined a pivotal role for both zebrafish homologs 
(rbm24a and rbm24b) in the genesis of the cardiovascular system (Maragh et al., 2011). 
In addition to the reported cardiovascular defects, there was an apparent impairment to 
the development of other embryonic systems. In this chapter we more generally 
investigate the expression and functional requirement for RBM24 in normal early 
embryonic development using the zebrafish model system.  The results of this study 
present the zebrafish RBM24 homologs as important players in the regulation of somite 




3.2.1 rbm24a and rbm24b are expressed in somites and presumptive skeletal muscle 
populations 
We initially identified Rbm24 in a screen for early cardiac genes and 
demonstrated it to be expressed at multiple time points during mouse cardiogenesis as 
well as in the somites (9.5 dpc) (Miller et al., 2008). Our subsequent cardiovascular-
focused studies in zebrafish determined a pivotal role for both zebrafish homologs 
(rbm24a and rbm24b) in the genesis of the cardiovascular system (Maragh et al., 2011). 
In addition to the reported cardiovascular defects, there was an apparent impairment to 
the development of other embryonic systems. Taking these data collectively we 
postulate that rbm24a and rbm24b may similarly contribute to the development of other 
systems in which they are expressed. To address this question we assayed the 
embryonic expression of rbm24a and rbm24b in the embryo throughout development. 
We detected transcripts corresponding to both rbm24a and rbm24b in the tailbud at the 
bud stage and in forming somites during somitogenesis via ISH (Figure 3-1).  By 8 
somites both rbm24a and rbm24b are expressed in patterned somites and somite 
progenitors (Figure 3-1 C, D). Somitic expression of both rbm24a and rbm24b persists 
through 24 hpf (Figure 3-1 E, F), at which time rbm24a transcripts are predominately 
localized in the most posterior somites and somites progenitors. By 48 hpf, however, 
rbm24a expression is undetectable in the somites by ISH (Figure 3-1 G). By contrast, 
rbm24b is expressed uniformly throughout all somites at 24 hpf, and remains readily 
detected in the somites at 48 hpf (Figure 3-1 F, H).   
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In addition to their somitic expression, both rbm24a and rbm24b were also 
detected in developing craniofacial structures (Figure 3-2 A).  The spatial expression 
pattern observed for each is consistent with multiple craniofacial muscle populations 
including those in the forming mandible, pharyngeal arches, otic vesicle and in optic 
muscles.  Taken collectively these data are consistent with potential roles in 
development for both Rbm24a and Rbm24b beyond those previously described in 
cardiovascular development (Maragh et al., 2011). 
 
3.2.2  Rbm24a and Rbm24b are required for normal somite and craniofacial 
development 
We evaluated the requirement for Rbm24a and Rbm24b during somite 
development, using MO technology to elicit knock down of each protein product 
independently.  We previously assayed the efficacy of both translation-blocking and 
splice-blocking MOs designed against rbm24a and rbm24b transcripts (Maragh et al., 
2011). The translation-blocking MOs consistently displayed higher efficiency although 
both classes of MO resulted in the same phenotype (Maragh et al., 2011). We, therefore, 
used translation blocking antisense MO to evaluate the independent impacts of Rbm24a 
or Rbm24b knockdown on somite integrity and directly compared rbm24aMO and 
rbm24bMO injected embryos to embryos injected using a control non-targeting 
morpholino (ctrlMO).  Reduction of either Rbm24a (rbm24aMO) or Rbm24b 
(rbm24bMO) disrupted normal somite patterning (Figure 3-3). At the 8 and 13 somite 
stages, rbm24aMO embryos frequently lacked distinct inter-somitic boundaries among 
multiple somites. By contrast although somitic boundaries remained in rbm24bMO 
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embryos their somites were laterally distended and demonstrated compression along the 
A-P axis (Figure 3-3 A-F). As further evidence of impaired somitogenesis in 
rbm24aMO and rbm24bMO embryos, the internal angle of somitic chevrons were 
measured in 13 somite stage embryos.  The internal chevron angle was measured for 
somites 6-10 individually as representative for each embryo. We observed the internal 
angle of somitic chevrons to be significantly more obtuse among rbm24aMO (p≤0.037) 
and rbm24bMO (p≤0.0029) embryos when compared to ctrlMO embryos (n= 3-5 per 
treatment; Figure 3-3 V). There was no significant difference in chevron angle, 
however, between uninjected and ctrlMO injected embryos. 
Dysmorphic somites persisted in rbm24aMO and rbm24bMO embryos at 24 
hpf, and showed no sign of recovery after the completion of somite pattering (48 hpf), 
rather both showed an additional curving tail phenotype (Figure 3-3 G-U).  We then 
assayed the phenotypes of rbm24aMO and rbm24bMO embryos based upon the 
expression of myod and dystrophin (dyst) (Parsons et al., 2002) established markers of 
somites and inter-somitic boundaries, respectively. ISH for myod and dyst clearly reveal 
the persistence of the somite patterning disruption in rbm24aMO and rbm24bMO 
embryos throughout patterning (24 hpf) and beyond (48 hpf). Although the effect of 
Rbm24a reduction on somite organization remained most marked in the posterior 
somites, consistent with localization of its expression, the structure of more rostral 
somites was also perturbed (Figure 3-3 K).  rbm24aMO embryos also showed marked 
reduction of dyst at 24 hpf, indicating that the integrity of somitic boundaries was 
compromised (Figure 3-3 N).  These defects persisted at 48 hpf with dramatic defects in 
somitic structure remaining among rbm24aMO embryos (Figure 3-3 T).  Similarly, the 
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effects of Rbm24b reduction were obvious at 24 hpf (Figure 3-3 L). The integrity of 
truncal somites was severely compromised and dyst signal was completely ablated 
(Figure 3-3 O). By contrast with rbm24aMO embryos, somite structure of rbm24bMO 
embryos recovered significantly by 48 hpf as seen by myod expression (Figure 3-3 U). 
This may reflect recovery enabled by the persistent expression of Rbm24b beyond the 
effective window of the corresponding MO. 
In addition to these somite phenotypes, abnormalities in craniofacial 
development were also detected in rbm24aMO and rbm24bMO embryos consistent 
with their observed spatial and temporal expression (Figure 3-2 B).  Independent MO-
based knockdown of either Rbm24a or Rbm24b resulted in shortened mandible, 
reduction in the size of the otic vessicle, micropthalmia and microcephaly.  Effects on 
the development of these structures, however, appeared more pronounced in 
rbm24aMO embryos (Figure 3-2 B).  Craniofacial muscle patterning at 72 hpf in 
mandibular, pharangeal arch, optic and fin bud muscle was reduced in both rbm24aMO 
and rbm24bMO embryos.  Alcian blue cartilage staining at 96 hpf revealed a dramatic 
reduction of the craniofacial cartilage in rbm24aMO and rbm24bMO embryos yielding 
little to no signal corresponding to the ethmoid plate, palatoquadrate, hyomandibular 
and Meckel’s cartilage (Figure 3-2 B).  By 48 hpf  and continuing through 96 hpf, 
concurrent with somite and craniofacial defects, we also observed our previously 
described cardiovascular defects in rbm24aMO and rbm24bMO embryos (Maragh et 
al., 2011). 
RNA rescue experiments were performed to confirm the specificity of MO 
phenotypes. As with previously described cardiac phenotypes, all observed rbm24aMO 
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and rbm24bMO somite and craniofacial phenotypes were appropriately alleviated in at 
least 74% of embryos via mRNA rescue (Figure 3-2 C, Figure 3-3 W-Z).   
These results suggest both Rbm24a and Rbm24b function early in 
somite/skeletal and craniofacial muscle patterning and are required for normal 
development.   
 
3.2.3 Knockdown of Rbm24a or Rbm24b does not deplete myogenic regulatory 
factors or MPCs  
MRFs Myf5, Myod, Myog and Myf6 are pivotal components of myogenesis, 
and their genes are expressed sequentially in myotome precursors beginning with myf5 
in the PSM and somite progenitors. This is followed by myod expression in somite 
progenitors and somites, contributing to maturation of myoblasts.  Myoblast fusion to 
form myofibers then terminally differentiated myotubes requires myog and myf6 
expression (Coutelle et al., 2001; Osborn et al., 2011).  To characterize the Rbm24 
knockdown phenotype during somitogenesis in greater depth we performed ISH with 
probes to the MRFs at the 13 somite stage of development.  We previously used ISH 
against myod as a somite marker and found no qualitative loss of myod while observing 
aberrant somite morphology (Figure 3-2 D-E).  Likewise, we did not observe 
quantitatively reduced expression of any MRF in rbm24aMO or rbm24bMO embryos 
compared to ctrlMO embryos (13 somite stage, Figure 3-5).  However, at the same 
stage, spatial distribution of myf5, myog and myf6 was consistent with brightfield 
observations of rbm24aMO and rbm24bMO embryo somite phenotypes.  In the PSM 
myf5 expression was more markedly expanded in rbm24bMO embryos compared to 
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rbm24aMO and ctrlMO embryos. Spatial expression of myf5, myog and myf6 were 
similarly distorted in segmented somites of rbm24aMO and rbm24bMO embryos 
highlighting once again the observation of compressed somites along the A-P axis of 
rbm24bMO embryos with additional severe lateral distention. 
 
3.2.4 Double knockdown of rbm24a and rbm24b effects somites with greater 
severity  
Knockdown experiments evaluating the impact of rbm24a or rbm24b depletion 
on cardiovascular experiments revealed a more severe cardiac phenotype was achieved 
upon double knockdown of rbm24a and rbm24b in the same embryo (Maragh et al., 
2011).  This was investigated here in relation to the observed somite phenotype.  Half 
the effective dose of both rbm24a and rbm24b MOs (2.5 ng and 4 ng respectively) were 
injected in the same embryo and compared embryos injected with to full doses of only 
one rbm24 MO (5 ng and 8 ng respectively).  A much more severe phenotype resulted 
in the morphants receiving both MOs in concert (Figure 3-4).  The double morphants 
displayed more indistinct somite boundaries at 8 somites than either morphant alone.   
By 30 hpf, the double morphants also displayed increased somite compression along the 
A-P axis and considerable tail kinking. These data support and confirm the previous 




3.3  Conclusions 
We previously demonstrated that the gene encoding Rbm24 is expressed during 
mouse cardiogenesis, and determined its zebrafish homologs, Rbm24a and Rbm24b, are 
essential for cardiac and vascular development.  We undertook in this set of studies to 
more completely evaluate requirement of Rbm24a and Rbm24b in early embryonic 
development.   
We demonstrate here by whole embryo ISH that both rbm24a and rbm24b are 
expressed by the bud stage of development and are subsequently expressed in the PSM 
and somites during segmentation.  During segmentation, spatial detection of rbm24a 
was more concentrated in the posterior trunk in the most nascent somites, while rbm24b 
expression appeared equally present in all somites.  After the completion of 
segmentation rbm24a expression was no longer detectable in the somites, while rbm24b 
expression was continually detected.  After segmentation both rbm24a and rbm24b 
were detected in developing craniofacial structures spatially and temporally consistent 
with craniofacial muscle populations. 
Functional evaluation of the requirement of Rbm24a and Rbm24b using 
translation blocking antisense MO revealed both Rbm24a and Rbm24b are required for 
normal somite and craniofacial development. rbm24aMO and rbm24bMO embryos 
exhibited  somite patterning defects and malformation of craniofacial structures.  These 
MO induced phenotypes were not consistent with simply developmental delay and were 
rescued upon microinjection of either respective mRNA.  Characterization of the somite 
phenotype using MRF markers suggests somite patterning defects do not result upon a 
loss of MRF expression.   
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These studies uncover a previously unreported requirement for Rbm24a and 
Rbm24b in somite and craniofacial development.  Further they highlight the value of 







3.4.1 Zebrafish Maintenance 
Adult AB,zebrafish lines were maintained in system water according to standard 
methods (Westerfield, 1995).  Embryos were obtained from natural mating of adult fish.   
 
3.4.2 Morpholino injection & mRNA rescue 
rbm24aMO and rbm24bMO embryos were generated by injection of previously 
published rbm24a and rbm24b translation blocking antisense morpholinos into 1-2 cell 
stage embryos at 5 ng and 8 ng respectively (Maragh et al., 2011).  The standard Gene 
Tools negative control morpholino oligo (CCTCTTACCTCAGTTACAATTTATA) 
was injected into 1-2 cell stage embryos at 8 ng to generate ctrlMO embryos.  Double 
MO embryos were generated by co-injecting 2.5 ng rbm24aMO with 5 ng rbm24bMO 
in a single injection solution.  mRNA rescue experiments were performed as previously 
described (Maragh et al., 2011). 
 
3.4.3 Microscopy 
Brightfield images were acquired on a Zeiss Luminar.V12 Stereoscope and a Nikon 
AZ100 dissecting microscope with white light. Zeiss Stereoscope images were analyzed 





3.4.4 Whole embryo in situ hybridization & Alcian Blue cartilage staining 
Beginning at 24 hpf AB embryos were treated with 0.003% PTU to reduce 
pigmentation. Embryos were fixed in 4% paraformaldehyde in PBS overnight at 4°C.  
Antisense RNA in situ hybridization was performed on bud, 8 somite, 13 somite, 24 
hpf, 48 hpf and 72 hpf zebrafish embryos with methods previously reported (Maragh et 
al., 2011).  Alcian blue cartilage staining was performed on 96 hpf embryos using 




3.5 Figures:  Chapter 3 
 
Figure 3-1. rbm24a and rbm24b are expressed throughout somitogenesis.   
 
ISH images of uninjected AB embryos using rbm24a or rbm24b riboprobes individually 
marking spatial and temporal RNA expression. Tailbud expression of bud stage 
embryos (Raya et al.).  8 somite embryos in dorsal facing orientations show all 
patterned somites marked by rbm24a and rbm24b riboprobes (C-D).  Trunk images of 
embryos at 24 hpf show spatial expression of rbm24a in the somites concentrated at the 
posterior, while rbm24b is uniformly expressed in somites along the A-P axis (E-F).  
Embryos at 48 hpf show no somite rbm24a expression, while somite expression of 
rbm24b remains uniform thought the somites (G-H). som, somites; hpf, hours post 
fertilization. 
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Figure 3-2. Rbm24a and Rbm24b are required for craniofacial development. 
 
Brightfield, ISH, and alcian blue images of ctrlMO, rbm24aMO and rbm24bMO 
embryos.  72 hpf lateral oriented embryos show expression of rbm24a and rbm24b in 
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presumptive optic muscles, pharyngeal arch muscles, mandibular muscles, and fin bud.  
rbm24a shows additional expression in the otic vesicle (A).  The anterior region of 72 
hpf and 96 hpf embryos are shown oriented laterally for visualization of eye and 
mandible phenotypes (B). Brightfield and ISH images of myod expression in the 
anterior region of dorsally oriented 72 hpf ctrlMO, rbm24aMO and rbm24bMO 
embryos (B rows 1 and 2). myod expression is detected in the find bud, optic muscles, 
pharyngeal arch muscles and mandibular muscles of uninjected embryos.  Normal myod 
expression is diminished in rbm24aMO and rbm24bMO embryos. Brightfield and 
alcian blue cartilage staining of ctrlMO, rbm24aMO and rbm24bMO embryos in lateral 
orientation at 96 hpf (B rows 2 and 3).  Normal cartilage staining is observed in the fin 
buds, ethmoid plate, palatoquadrate, hyomandibularand Meckel’s cartilage of 
uninjected embryos.  Cartilage formation of these structures is ablated in rbm24aMO 
embryos and severely reduced in rbm24bMO embryos.  Brightfield craniofacial images 
of RNA rescue rbm24aMO and rbm24bMO phenotypes at 96 hpf (C).  rbm24aMO 
rescue, by co-injection of 5 ngrbm24aMO with 800 pg of capped poly-A rbm24a 
mRNA and rbm24bMO rescue, by co-injection of 8 ngrbm24bMO with 200 pg of 
capped poly-A rbm24b mRNA, show rescue of somite and craniofacial rbm24aMO and 
rbm24bMO phenotypes.  fb, fin bud; om, optic muscles; ov, otic vesicle; ph, pharyngeal 
muscles; mm, mandibular muscles. white arrow, eye; black arrow, mandible; m, 
Meckel’s cartilage; ep, ethmoid plate; pq, palatoquadrate; hm, hyomandibularcartilage.   
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Figure 3-3. Rbm24a and Rbm24b are required for normal somitogenesis. 
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Brightfield and ISH images of ctrlMO, rbm24aMO and rbm24bMO embryos. 
Brightfield 8 somite embryos are shown in dorsal orientation (A-D). Spatial expression 
of myod in somites of 13 somite embryos was detected using antisense DIG labeled 
riboprobes (D-F).  The trunks of 24 hpf embryos are shown in the lateral orientation via 
live imaging (G-I), myod ISH (J-L), and dyst ISH (M-O).  48 hpf embryos are shown in 
the lateral orientation via live imaging (P-R) and myod ISH (S-U).  Measurements of 
individual chevron angle measurements of somites 6-10 of 13 somite embryos for 
uninjected, ctrlMO injected rbm24aMO and rbm24bMO embryos, n = 3-5 embryos 
each (V).  Statistically significant differences in lateral length and somite angle as 
compared to ctrlMO is shown using an asterisk.  mRNA phenotype rescue of 
rbm24aMO embryos with rbm24a mRNA and rbm24bMO embryos with rbm24b 
mRNA imaged at 24 hpf (W-X) and 48 hpf (Y-Z).  *= p<0.05; **= p<0.01; hpf, hours 
post fertilization.   
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Figure 3-4. doubleMO embryos show a more severe somite phenotype than 
individual rbm24aMO and rbm24bMO embryos 
 
Brightfield imaging of 8 somite and 24 hpf embryos injected with rbm24aMO (5 ng) 
(A, D), rbm24bMO (8 ng) (B, E) or half doses of both rbm24a (2.5 ng) and rbm24b (4 
ng) MOs (C, F).  
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Figure 3-5.  MRF expression is not repressed in rbm24aMO and rbm24bMO 
embryos.   
 
ISH images of 13 somite ctrlMO, rbm24aMO and rbm24bMO embryos.  Spatial 
expression of myf5 in somite precursors and PSM (A-C), myog (D-F) and myf6 (G-I) in 





COMPONENTS OF THE NOTCH-SIGNALING PATHWAY ARE 




We focus in this chapter on understanding the requirement of both Rbm24a and 
Rbm24b in somite development because it is the earliest developing muscle population 
in which we observed both expression and developmental malformation.  Somite 
patterning originates within a niche of undetermined MPCs in the tailbud shortly after 
the conclusion of gastrulation.  Multiple pathways contribute to the maintenance of 
MPCs and subsequent somite segmentation, patterning and specification (Kimelman, 
2006; Niwa et al., 2011; Szeto and Kimelman, 2006; Tiedemann et al., 2012). Notch-
mediated signaling is among several pathways that play key roles in segmentation and 
somite patterning (Bray, 2006; High and Epstein, 2008; Oates and Ho, 2002).  
Specifically, ligands genes dlc and dld and downstream target genes her1 and her7 are 
critical components of somitogenesis and the segmentation clock.   The protein products 
of these genes act via cyclical cell-cell signaling within MPCs and somite progenitors 
(Giudicelli et al., 2007; Julich et al., 2005; Oates et al., 2005; Schroter et al., 2012; 
Trofka et al., 2012).  The cycling expression of these ligands and target genes persists 
through to the completion of somitogenesis and is partially maintained by negative 
feedback of target gene proteins on transcription of dlc and dld (Giudicelli et al., 2007; 
Holley et al., 2000).   
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Our data reveal perturbations in Notch pathway components as one possible 
contributor to abnormal somite phenotypes resulting from Rbm24a or Rbm24b titration 
in vivo. We provide evidence that zebrafish RBM24 homologs may normally act to 
ensure appropriate pre-mRNA processing of the dlc and dld transcripts that encode 
Notch ligands in PSM cell populations. We propose that perturbation of Notch-
mediated signaling may, in part, explain the somitic deficits observed upon disruption 





4.2.1 Notch-pathway genes are reduced in rbm24aMO and rbm24bMO embryos 
Given the demonstrable somite deficits upon Rbm24 knockdown, we 
investigated whether the Notch clock genes (Figure 4-1) were perturbed in rbm24 
morphant embryos.  At the 13 somite stage dlc expression was almost ablated in the 
PSM in both rbm24aMO and rbm24bMO embryos (Figure 4-1 A-C). Further, dld 
expression was diminished in rbm24bMO embryos (Figure 4-1 D -F).  Expression of 
the target genes her1 and her7 in the PSM was also diminished in both rbm24aMO and 
rbm24bMO embryos (Figure 4-1 G-L).Notwithstanding the observed reduction in dlc, 
dld, her1 and her7 expression, tbx16 expression marking MPCs was unchanged in 
rbm24MO embryos, indicating the reduced expression of Notch components does not a 
result from an absence of MPCs within the PSM (Figure 4-1 M-O).  By 24 hpf, 
expression of dlc, dld, her1 or her7 failed to recover in either rbm24aMO or 
rbm24bMO embryos. In fact, their expression appeared to be further diminished 
compared with earlier time points, without the loss of tbx16 expression (Figure 4-1 P-
DD). The observed reduction of her1 and her7 expression suggests it is unlikely that the 
observed reduced dlc and dld levels results from negative feedback on ligand 
transcription levels caused by increased her1 or her7 transcripts.  In the PSM and 
somite precursors, cell-cell signal transduction of Dlc and Dld ligands is mediated 
through cell surface receptors on neighboring cells (Bray, 2006; Cinquin, 2007), and 
receptors Notch1a and Notch3 are known components of the somite clock (Beres et al., 
2011; Sieger et al., 2003).  While we observed expression reduction of assayed ligands 
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and target genes, we did not observe altered expression of notch1a or notch3 transcripts 
(Figure 4-2). 
To determine whether the effects on Notch signaling were restricted to evaluated 
tissues, we then assayed in the impact of rbm24a and rbm24b depletion on dla, dlb and 
dll4 transcripts.  Dla, Dlb and Dll4 are Notch ligands that are not involved in somite 
patterning.  Expression levels of dla or dlb (expressed neural cells), were not perturbed 
in rbm24aMO and rbm24bMO embryos at 24 hpf (Figure 4-3). Transcript 
corresponding to dll4 and its cognate target gene hey2, however were disrupted in both 
rbm24aMO and rbm24bMO embryos (Figure 4-3). Spatial expression of dll4 and hey2 
is largely depleted in rbm24aMO embryos and diminished rbm24bMO embryos 
compared with uninjected controls.  dll4 and hey2 are known to be required for arterial 
vasculature formation (Scehnet et al., 2007), and this observation is consistent with our 
previously published finding that rbm24aMO embryos are unable to form the dorsal 
aorta (Maragh et al., 2011).   
These studies indicate the transcripts for Notch ligands and their target genes, 
which are requisite for normal somitogenesis, are depleted as a consequence of 
knockdown of either rbm24 homolog. Additionally the same may be postulated for 
Notch ligands in vascular development.  These data implicate dysregulation of Notch 
signaling as a potential contributor to rbm24aMO and rbm24bMO phenotypes.  Taking 
these findings together we further postulate disruption of Notch somite clock 
components is likely occurring at the level of ligand regulation. 
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4.2.2 The Notch-Signaling Pathway is dysregulated in the hearts of rbm24aMO and 
rbm24bMO embryos 
Cardiac muscle is among the many embryonic tissues whose development is 
influenced by the Notch-signaling pathway.   Defects in human NOTCH1 and 
associated proteins underlie malformations including cardiac septa and valve defects 
(Garg et al., 2005; McBride et al., 2008).  We previously reported rbm24aMO or 
rbm24bMO embryos present with heart tube distention, cadiac looping and 
atrioventricular septation defects.  To test the hypothesis that reduced Notch signaling, 
may also contribute to cardiac defects,  we directly assayed Notch signaling in 
rbm24aMO and rbm24bMO embryos, using the zebrafish Tg(Tp1bglob:hmgb1-
mCherry)
jh11
, Notch-reporter line (Parsons et al., 2009). This transgenic line expresses a 
nuclear-localized mCherry fluorophore in cells undergoing Notch signaling.  At 48 hpf 
Notch signaling was reduced around the atrioventricular septum in rbm24aMO or 
rbm24bMO embryos compared to uninjected controls (Figure 4-4).   
 We also wanted to determine whether reduction of rbm24a or rbm24b 
might also reduce signaling through another developmentally critical pathway. Thus we 
extended these analyses to include a zebrafish reporter lines for BMP Tg(BRE:eGFP) 
(Laux et al., 2011) signaling pathway, whose dysregulation might also contribute to the 
genesis of the observed cardiac or craniofacial phenotypes. While rbm24aMO and 
rbm24bMO embryos displayed the cardiac phenotypes associated with knockdown, 
BMP reporter activity was not reduced in cardiac or craniofacial structures as compared 
to uninjected controls at 48 hpf (Figure 4-4).  Taken collectively these data support the 
hypothesis that Notch-signaling activity is reduced/altered in cardiac tissue of 
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rbm24aMO and rbm24bMO embryos.  While this effect is stronger than any observed 
for other assayed pathways, we cannot exclude possible contributions from other 
developmental pathways to the resulting rbm24aMO or rbm24bMO phenotypes at this 
time.   
4.2.3 Rbm24a & Rbm24b knockdown phenotypes do not appear to be due to 
gastrulation defects 
We evaluated whether observed rbm24aMOand rbm24bMO phenotypes were a 
consequence of gastrulation defects whose effects we were simply observing later in 
development.  These phenotypes would include incomplete migration of cells during 
gastrulation, disorganized cellular organization at the tailbud, notochord distention or 
notochord kinking. (Yin and Solnica-Krezel, 2007).  We performed live imaging and 
ISH for embryos evaluated at 75% epiboly and bud stages and found no observable 
deleterious phenotypes (Figure 4-5).  These data suggest gastrulation occurs 
comparatively normally in rbm24 morphants.  Later in development one consequence of 
gastrulation defects can be observed as an increase in notochord width (Glickman et al., 
2003).  We observed no difference in notochord width between uninjected (38.37m +/- 
1.40), ctrlMO (37.72 m +/- 2.48), rbm24aMO (38.73m +/- 1.12), and rbm24bMO 
(38.83 m +/- 1.23) embryos (p > 0.3) at the 13 somite stage.  The findings from our 




4.2.3 Aberrant dlc and dld transcripts are present in rbm24aMO and rbm24bMO 
embryos   
Our findings thus far investigating somite development support a model in 
which reduction of either Rbm24a or Rbm24b results in both aberrant somitogenesis 
and reduced expression of the transcripts encoding Notch ligands, Dlc and Dld, along 
with those of their subsequent target genes, Her1 and Her7.  We hypothesized that the 
reduction in Notch signaling is occurring at the ligand level.  Recent reports suggest that 
the homolog for RBM24 in C. elegans (SUP-12) is a splicing factor active in muscle 
(Hamlett et al., 1992; Kuroyanagi et al., 2007; Ohno et al., 2012).  Additionally several 
other RBM proteins are known to function as post transcriptional regulators and 
splicing factors (Gao et al., 2011; Guo et al., 2012; Jin et al., 2012; Kar et al., 2006; Li 
et al., 2013; Pedrotti et al., 2012; Suvorova et al., 2013; Yeo et al., 2009; Zhang et al., 
2008; Zhou et al., 2008).  While there have been no reports of RBM24 or other RBMs 
impacting the Notch pathway, based on the known role of RBMs in splicing we posited 
that a reduction of Rbm24a or Rbm24b would result in incorrect processing of pre-
mRNA dlc and dld transcripts.   
To test this hypothesis we designed primers within the 5’ and 3’ UTRs of dlc, 
dld, her1 and her7 to amplify across the coding region of each transcript. Using random 
hexamer-generated cDNA from 13 somite and 24 hpf uninjected, ctrlMO, rbm24aMO 
and rbm24bMO embryos, we performed RT-PCR and detected fragments of the 
expected size for full length dlc, dld, her1 and her7 mRNA from all cDNA samples.  
However, in cDNA generated from rbm24aMO and rbm24bMO embryos we also 
detected additional fragments shorter than the predicted sizes for dlc (dlc short_1) and 
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dld (dld short_1 & dld short 2) transcripts (Figure 4-6).  All dlc and dld short fragments 
were detected solely in cDNA from both rbm24aMO and rbm24bMO embryos.  No 
fragments in addition to wildtype were detected for her1 or her7 (data not shown).  We 
then subcloned and sequenced the short dlc and dld amplicons, verifying them to be 
aberrant transcript variants of each respective pre-mRNA transcript.  Sequence 
alignment of these fragments with the corresponding wildtype mRNA showed aberrant 
processing occurred in 3/3 instances such that between 5-7 exons were skipped and a 
unique junction formed by the joining of two truncated exons (Table 4-1). Wildtype dlc 
mRNA consists of exons 1-9 yielding 1,995 coding nucleotides (nt), while dlc short_1 
consist of a truncated exon 1 (missing the last 11 nt) joined directly to a truncated exon 
7 (missing the first 483 nt) with subsequent normal splicing to the inclusion of exons 8 
and 9 for a coding length of 372 nt (Figure 4-6 A).  Wildtype dld mRNA consists of 
exons 1-11 yielding 2,154 coding nt, while dld short_1 consist exons 1-4 where exon 4 
is truncated (missing the last 4 nt) joined directly to the 3’ UTR region of exon 11 such 
that the reading frame would include an additional 9 nt then a stop codon for a coding 
length of 612 nt; dld short 2 consists of a truncated exon 1 (missing last 8 nt) joined to a 
truncated exon 9 (missing the beginning 771 nt) followed by the retention of intron 9 
(80 nt) and exon 10 with normal splicing and inclusion of exon 11 for a coding length 
of 256 nt (Figure 4-6 A).  Mapping of all potential splice donor and acceptor sequences 
that could yield the identified short fragments revealed no cryptic splice sites around the 
break points of the truncated exons (Mount, 1982; Shapiro and Senapathy, 1987).  
These aberrant fragments therefore appear to have been generated via an alternate 
mechanism as oppose to canonical splice site recognition.  Further sequence analysis 
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indicated none of the short fragments detected would be predicted to be functional.  All 
short fragments lack motifs (delta-serrate domain or EGF-like domain repeats) required 
for the extracellular binding of Delta ligands to Notch receptors, and dld short 2 is also 
predicted to undergo nonsense-mediated decay. Using quantitative RT-PCR (qRT-PCR) 
on cDNA samples generated from 13 somite stage and 24 hpf embryos, wildtype dlc 
and dld mRNA levels were significantly decreased in cDNA generated from 
rbm24aMO and rbm24bMO embryos but not ctrlMO embryos, compared to uninjected 
controls (Figure 4-6).  We then assayed the relative abundance of the two aberrant dld 
mRNA splice forms, and found these fragments detectable by qRT-PCR in cDNA from 
rbm24aMO and rbm24bMO embryos. However, neither short variant RNA fragment 
was detectable in cDNA from uninjected or ctrlMO embryos (data not shown).   
These data support a model in which a reduction of either rbm24a or rbm24b 
results not only in a significant reduction of wildtype dlc and dld mRNA levels but also 
a molecular perturbation of the pre-mRNA transcripts of these genes by which there is 
production of aberrantly mRNA transcripts that are not readily detectable in uninjected 
or ctrlMO embryos.  Our data suggest both rbm24a andrbm24b participate in post-




In this section we uncover a link between the depletion of Rbm24a or Rbm24b 
and the Notch signaling pathway.  We demonstrate here that transcript levels of dlc, dld, 
her1 and her7 encoding Notch-signaling pathway proteins critical for normal 
somitogenesis are depleted upon Rbm24a or Rbm24b knockdown.  Further we 
demonstrate that this perturbation to Notch-signaling pathway transcripts is not largely 
general and does not impact transcripts encoding the neuronally expressed Notch 
ligands Dla and Dlb.  However, investigations into Notch-signaling pathway 
components involved in cardiovascular development revealed a reduction of Notch 
signaling in the heart in a reporter assay and reduction of vascular ligand dll4 and target 
gene hey2 transcripts via ISH.   
Our data reveal perturbations in Notch pathway components as one possible 
contributor to abnormal cardiovascular and somite phenotypes resulting from Rbm24a 
or Rbm24b titration in vivo. We provide evidence that zebrafish RBM24 homologs may 
normally act to ensure appropriate pre-mRNA processing of the dlc and dld transcripts 
that encode Notch ligands in PSM cell populations. We propose that perturbation of 
Notch-mediated signaling may, in part, explain the somitic deficits observed upon 
disruption of Rbm24 levels.  
 




4.4.1 Zebrafish Maintenance 
Adult AB, zebrafish lines were maintained in system water according to standard 
methods (Westerfield, 1995).  Embryos were obtained from natural mating of adult fish.   
 
4.4.2 Microscopy 
Brightfield and images were acquired on a Zeiss Luminar.V12 Stereoscope and a Nikon 
AZ100 dissecting microscope with white light. Zeiss Stereoscope images were analyzed 
with Zeiss AxioVision 4.8 software for embryo lateral length and somite angle 
measurements. 
 
4.4.3 Whole embryo in situ hybridization 
Beginning at 24 hpf AB embryos were treated with 0.003% 1-phenyl-2-thiourea (PTU) 
to reduce pigmentation. Embryos were fixed in 4% paraformaldehyde in PBS overnight 
at 4°C.  Antisense RNA in situ hybridization was performed on 75% epiboly, bud, 13 
somite and 24 hpf zebrafish embryos with methods previously reported (Maragh et al., 
2011).  Riboprobe primer sequences are listed in Table 4-2. 
 
4.4.4 Splice variant RT-PCR and qRT-PCR 
Total RNA was isolated from AB uninjected, ctrlMO, rbm24aMO and rbm24bMO 
whole zebrafish embryos at 13 somite and 24 hpf stages (n = 50 embryos per stage) 
using TRIzol Reagent.  cDNA was generated from 2 µg RNA with random hexamers 
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using the SuperScriptIII First-Strand Synthesis Kit (Invitrogen).  RT-PCR was 
performed on embryo cDNA with primers designed to the 5’ and 3’ UTRs of dlc, dld, 
her1 and her7.  RT-PCR fragments were analyzed for size and Sanger sequencing was 
performed.  qRT-PCR primers were designed to detect elfalpha, dlc, and dld wild-type 
transcripts as well as dld short_1 and dld short 2 transcripts.  Primers for dlc and dld 
wild-type transcripts were designed in exons not present short dlc and dld transcripts.  
Primers to detect short dld fragments were designed across the unique splice junction 
present in these transcripts. qRT-PCR was performed in triplicate using Power SYBR 
Green (Applied Biosystems) on the Viia 7 Real-Time PCR System (Applied 
Biosystems).  Fold amplification was determined via the delta-delta Ct method 
normalizing to endogenous control elfalpha and AB uninjected embryos.  A students t-
test was used to determine significance at p < 0.05 *, p < 0.01** and p < 0.001***.  RT-




4.5 Tables:  Chapter 4 
 
Table 4-1.   Splice junctions of detected dlc and dld fragments.  
 
Exon boundaries are listed for each fragment detected and in Figure 4-6.  Truncated 
exons are noted by numbers in parenthesis.  Truncations on the 3’ end are listed to the 
right of exon lengths and truncations on the 5’ end are listed on the left of exon lengths.  
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Table 4-2. Primer sequences. 
 
Primers used to generate antisense DIG labled riboprobes, conduct splice variant RT-
PCR and conduct qRT-PCR are listed. 
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4.6 Figures:  Chapter 4 
 
Figure 4-1.   Notch-signaling pathway transcripts are depleted in somites of 
rbm24aMO and rbm24bMO embryos 
 
ISH images of the tailbud region of dorsally oriented 13 somite and laterally oriented 24 
hpf ctrlMO, rbm24aMO and rbm24bMO embryos. 13 somite tailbud spatial expression 
of dlc (A-C), dld (D-F), her1 (G-I) and her7 (J-L) and tbx16 (M-O) in the PSM and 
somite precursors using respective antisense DIG labeled riboprobes.  24 hpf tailbud 
spatial expression of dlc (P-R), dld (S-U), her1 (V-X) and her7 (Y-AA) and tbx16 (BB-
DD). black arrows, regions of interest for tailbud expression. 
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Figure 4-2.  notch1a and notch3 transcripts do not shown reduced tailbud 
expression in  rbm24aMO and rbm24bMO embryos.   
 
ISH of Notch pathway receptors transcripts notch1a (A-C) and notch3 (D-F) in the 




Figure 4-3. ISH  of  neutrally and vascularly expressed Notch-pathway 
transcripts in rbm24aMO and rbm24bMO embryos.   
 
ISH images of the trunk region of laterally oriented 24 hpf uninjected, rbm24aMO and 
rbm24bMO embryos. Spatial expression of dla & dlb in cells of the central nervous 
system is not depleted; while dll4 & hey2 spatial expression in the vasculature is 
depleted.  asterisk, dorsal aorta expression, black brackets, posterior cardinal vein 
expression. 
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Figure 4-4. Notch and BMP reporter activity in rbm24aMO and rbm24bMO 
embryos.  
 
Fluorescent images of Notch-reporter activity using theTg(Tp1bglob:hmgb1-
mCherry)
jh11
, reporter line and BMP reporter activity using the Tg(BRE:eGFP) reporter 
line at 48 hpf.  Hearts of uninjected, rbm24aMO and rbm24bMO Tg(Tp1bglob:hmgb1-
mCherry)
jh11 
embryos were imaged in the lateral orientation.  Notch-reporter activity 
was recorded in the heart concentrated at the A-V boundary for all conditions at 48 hpf, 
however with limited detection in rbm24aMO and rbm24bMO embryos (A-C).  Hearts 
of uninjected, rbm24aMO and rbm24bMO Tg(BRE:eGFP) embryos in the ventral 
orientation show strong detection of BMP activity in all conditions (D-F).  Strong BMP 
expression is detected in the pharengeal arches of laterally oriented embryos for all 
 85 
conditions.  dotted outline, heart chamber boundaries; v, ventricle; a, atrium; double 
arrow, A-V boundary; white bracket, pharyngeal arches; pha, pharyngeal arches.  
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Figure 4-5.   rbm24aMO and rbm24bMO embryos do not display gastrulation 
defects.   
 
ctrlMO, rbm24aMO and rbm24bMO embryos during gastrulation.  Brightfield imaging 
of 75% epiboly embryos (A-C). Brightfield imaging of bud stage (D-F).  ISH of bud 




Figure 4-6.   Aberrant dlc and dld splice forms are detectable in cDNA from 
rbm24aMO and rbm24bMO embryos.   
 
PCR experiments to amplify dlc and dld mRNA transcripts using total cDNA generated 
from 13 somite uninjected, ctrlMO, rbm24aMO and rbm24bMO embryos (n=50 
embryos per condition).  PCR for dlc transcript yielded a fragment of correct length for 
all conditions and an additional short fragment for rbm24aMO and rbm24bMO cDNA 
(A).  dlc pre-mRNA, dlc mRNA and dlc short_1 fragment sequences are depicted 
graphically to scale.  PCR for dld transcript yielded a fragment of correct length for all 
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conditions and two additional short fragments for rbm24aMO and rbm24bMO cDNA 
(B).  dld pre-mRNA, dld mRNA and dld short_1 and dld short 2 fragments are depicted 
graphically to scale. 13 somite and 24 hpfuninjected, ctrlMO, rbm24aMO and 
rbm24bMO embryos were used to generate cDNA used for qRT-PCR.  All transcripts 
were assayed in triplicate per cDNA sample.  Transcript levels were normalized to 
elfalpha transcript levels and fold change for each transcript is shown as compared to 
uninjected embryos.  Statistically significant fold changes compared to uninjected are 
denoted by an asterisk.  *= p<0.05; **= p<0.01; ***=p<0.001.  black arrows, short dlc 
and dld fragments; boxes, exons; thick black lines, introns; thin black lines, wildtype 











RBMs are a relatively poorly understood family of proteins, defined solely by 
the presence of RNA binding motifs (Nakano et al., 1992).  To date, only a small subset 
of RBMs have been recognized to be functionally significant in humans and model 
organisms (Albers et al., 2012; Guo et al., 2012; Jayasena and Bronner, 2012; Johnston 
et al., 2010; Lin and Tarn, 2012; Lin et al., 2013; Miyamoto et al., 2009; Nousbeck et 
al., 2008).  Recent work in a mouse model suggests that RBM24, encoding another 
family member, may similarly be developmentally critical  (Miller et al., 2008). 
Rbm24 is a cardiac gene candidate identified through transcript profiling of 
differentiating mESCs (Miller et al., 2008).  It was initially selected for functional 
analysis due to its early cardiac expression during mouse development, first detected by 
in situ hybridization in the cardiac crescent of mice, and subsequently in the heart tube 
and looping heart with additional signal observed in the somites.  This work set out to 
functionally investigate a role for RBM24 in cardiac and somite development using a 
zebrafish model system. 
 
5.2 Rbm24 homologs are essential for normal cardiovascular development 
 Syntenic and sequence-based comparative genomic analyses were employed to 
identify two Rbm24 homologs (rbm24a and rbm24b) in zebrafish.  It was established 
through ISH that in the zebrafish rbm24a and rbm24b expression was concordant with 
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earlier observations in mice.  In the zebrafish model, rbm24a and rbm24b expression 
were also clearly detected in the developing vasculature.  Knockdown experiments 
using splice blocking and translation blocking morpholino technologies revealed in the 
zebrafish embryo, a reduction of either Rbm24 homolog results in cardiac edema, 
cardiac looping defects, heart tube distention, and reduced to non existent circulation.  
General toxicity or off target effects as the cause of the observed morphant phenotype 
were excluded by confirming they remain without amelioration in the presence of p53 
MO.  Additionally RNA-based phenotype rescue successfully confirmed the morphant 
phenotypes are sequence-specific.  It was unclear if the low to no circulation phenotype 
was  a result of reduced cardiac contraction (Mitchell et al., 2010).  Heart rate counts of 
rbm24aMO or rbm24bMO injected embryos did not support that a low heart rate could 
explain the reduced to no circulation.  Observations of vasculature upon Rbm24a or 
Rbm24b knockdown in a GFP-endothelial reporter line (Cross et al., 2003) revealed 
Rbm24a and Rbm24b are required for normal vascular development.  Additionally, 
reduction of either Rbm24a or Rbm24b independently yielded vascular defects of both 
myocardium and endocardium.  It is therefore likely reduced circulation is due to a 
reduction in critical vasculature and not simply reduced heart rate. 
 Investigation of molecular markers for myocardial development further 
illuminated the impact of reducing rbm24 expression. Both rbm24 homologs are 
detected in the developing heart by in situ hybridization by 24 hpf and sustain 
expression at least through 72 hpf.  In all cases a reduction of rbm24a or rbm24b was 
sufficient to prevent heart looping noted at 48 hpf and beyond, where normal heart 
looping occurs at approximately 36 hpf.  Expression of rbm24a is unequal between the 
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ventricle and atrium with stronger expression in the atrium while rbm24b shows 
equivalent expression in both chambers.  This skewed expression of rbm24a at higher 
levels in the atrium is illustrated by truncated and abnormal atrium formation of the 
developing heart in rbm24a MO injected embryos demonstrating its requirement for 
cardiogenesis, including atrial specification, at this early stage. A reduction in either 
rbm24 homolog severely disrupts the expression level and localization of ventricular 
marker vmhc yielding little to no expression visible in either rbm24 morphant condition.  
Reduced ventricular myocardial count disproportionate to the atrium has also been 
reported with deficient nkx and hedgehog signaling (Targoff et al., 2008; Thomas et al., 
2008).  Although reduction of each rbm24 results in incompletely overlapping atrial and 
ventricular phenotypes, reduction of either is sufficient to compromise the looping of 
the heart tube.  The looping of the heart tube is a result of both genetic and biophysical 
mechanisms, and perturbation of the mechanical force generated by the contraction of 
the heart chambers can affect proper heart formation (Taber, 2006).  Zebrafish wea 
mutants (myh6), display distortions in cardiac looping, but still maintain a functional 
circulatory system due to the adaptation of the ventricle (Berdougo et al., 2003).  This 
suggests that reduction in rbm24a expression impacts both the ventricle and atrium, 
likely in the organization or structure of the muscle filaments, in addition to 
cardiomyocyte count, in turn affecting the ability of the heart to circulate blood. 
  Although both rbm24a MO and rbm24b MO injected embryos display an 
additional phenotype of aberrant vascular morphology, with defects in vasculogenesis 
and angiogenesis the defect in rbm24a morphants appears more severe. The observed 
phenotypes, however, are also consistent with the exhibited localization of each rbm24 
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homolog, wherein rbm24a is expressed in the DA and rbm24b is expressed in the PCV 
by 72 hpf. The expression difference likely reflects the acquisition of independent roles 
since duplication of the ancestral gene (Ekker et al., 1992; Kleinjan et al., 2008), 
resulting in incompletely overlapping functions for these homologs in vasculogenesis.  
Angiogenesis is impaired when expression of either rbm24 homolog is reduced.  The 
integrity of these first vessesls of angiogenesis (Se and two DLAVs) deteriorates over 
time.  In rbm24a morphants Se are more severely affected not reaching the dorsal line 
to form DLAVs at 48 hpf and continue to deteriorate by 72 hpf.  This may result form 
the lack of any discernable DA.  rbm24b morphants still possessed a visible DA but no 
PCV, Se and one DLAV were present and only displayed mild morphology alterations 
at 48 hpf with subsequent severe deterioration by 72 hpf.  In the case of all rbm24 
morphants there is an inability to maintain the new vessels formed during angiogenesis 
and a wasting of any vessels resulting from vasculogenesis.  It is unclear the molecular 
basis of this blood vessel deterioration.   Normal rbm24 expression may be playing a 
direct role in the vascular maintenance or the angiogenesis pathway.  Also to be 
considered is that a lack of sufficient concentrations of growth factors and mitogens due 
to insufficient circulation may be preventing maintenance of initiated vasculature, since 
it has been shown Se sprouting and extension involves several rounds of cell division 
(Blum et al., 2008) and vegfA is required for vascular maintenance (Bahary et al., 2007).    
The incompletely overlapping role of rbm24a and rbm24b in the developing 
heart and vasculature is underscored by the extreme phenotype observed in the double 
morpholino injections.  rbm24a and rbm24b appear to act in parallel in cardiac 
development, converging on a common phenotype for which they are both overtly 
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required.  By contrast in vasculogenesis, rbm24a and rbm24b appear to function in 
parallel but differentially in artery and vein formation, resulting in different vascular 
phenotypes which are individually sufficient to disrupt formation of the initial 
embryonic circulation loop.  Further analyses will be required to determine the 
mechanistic role played by rbm24a/b and whether their roles involve one or all of the 
above-discussed mechanisms. 
Our data provide significant insight into the role of rbm24 in formation of 
cardiac and vascular systems, however much remains to be learned about the exact 
mechanism by which it functions and the role RBM24 may play in human disease. 
Other RRM containing proteins have also been shown to serve important roles in 
embryonic development (Anyanful et al., 2004; Markus and Morris, 2006) and post-
transcriptional regulation is a frequent theme.  With this in mind, we hypothesize that 
the protein plays a role in the post-transcriptional regulation of gene expression 
important for cardiac and vascular development. In the case of rbm24a and rbm24b 
depletion for instance, we found that expression of the ventricular marker vmhc is 
nearly abolished in the heart at 72 hpf, suggesting they both may contribute to specific 
regulation of vmhc mRNA. This study demonstrates the power of the screen that 
uncovered Rbm24 as a candidate cardiac gene, adding significant value to the original 




5.3 Rbm24 homologs are essential for normal somitogenesis 
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Rbm24 has been shown to be expressed in somites early in development (Miller 
et al., 2008).  In this second part of this work we expanded upon our developmental 
analysis of rbm24a and rbm24b, focusing on the skeleto-muscular system.  We 
demonstrated that rbm24a and rbm24b are prominently expressed in the tailbud and 
forming somites throughout segmentation, consistent with recent reports that RBM24 
plays a role in myogenic differentiation (Jin et al., 2010; Li et al., 2010; Miyamoto et 
al., 2009).  Furthermore, we showed both genes to be expressed in developing 
craniofacial structures.  Spatial expression localization of rbm24a and rbm24b was 
consistent with that of the skeletal muscle marker myod, suggesting rbm24a and 
rbm24b may be expressed in developing skeletal muscle tissue throughout the embryo.   
Subsequent depletion of either Rbm24a or Rbm24b resulted in somite and 
craniofacial malformation, while also recapitulating our previous report of 
cardiovascular defects.    Somite dysmorphologies included somite boundary defects, 
somite compression along the A-P axis and tail curving.  Gross craniofacial 
malformations of a shortened mandible, reduction in the size of the otic vessicle, 
micropthalmia and microcephaly were detected upon knockdown of either Rbm24 
homolog.  All observed somitic and craniofacial phenotypes were appropriately 
ameliorated in RNA-based rescue experiments. 
Our findings suggest Rbm24a and Rbm24b are essential for skeletal muscle 
development in addition to their established roles in cardiac and vascular development.  
All of these tissues share origins in the mesoderm germ layer.  It is, therefore, possible 
that mesoderm-derived populations are particularly sensitive to depletion of Rbm24a or 
Rbm24b.   
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5.4 Depletion of Rbm24 homologs impacts the Notch-signaling pathway 
Notch signaling is critical for the patterning of many embryonic tissues 
including the heart, hematopoeitic system and somites (Bigas et al., 2010; High and 
Epstein, 2008; McBride et al., 2008; Oates and Ho, 2002; Oates et al., 2005; Scehnet et 
al., 2007).  During somite patterning the Dlc and Dld ligands function to activate Notch 
via of her1 and her7 target genes in neighboring cells in the PSM and somite precursors 
(Giudicelli et al., 2007; Oates et al., 2005).The normal functions of Her1 and Her7, 
include negative regulation of dlc and dld transcription which contributes to both 
perpetuation of the somite clock and maintenance of unsegmented cells within the PSM 
(Tiedemann et al., 2012). Mutants for dlc, dld, her1 or her7 exhibit a loss of somite 
boundaries and de-synchronization of the somite clock (Choorapoikayil et al., 2012; 
Holley et al., 2000; Tiedemann et al., 2012; van Eeden et al., 1996).  The reported 
somite phenotypes of dlc, dld, her1 and her7 mutants appear more severe than, and 
incompletely overlap with, those we observed for rbm24aMO and rbm24bMO embryos. 
We observed dorsal-ventral somite distortion, most notably in rbm24bMO embryos, 
which is not a documented phenotype of dlc, dld, her1 or her7 mutants.  Although we 
cannot restrict the impact of Rbm24 reduction to only one pathway, we did observe a 
diminution of dlc, dld, her1 and her7 transcript levels normally localized in MPCs in 
both rbm24aMO and rbm24bMO embryos.  Taken together these observations indicate 
dysregulation of these components of the Notch pathway is likely incomplete and may 
only partially account for rbm24aMO and rbm24bMO somite phenotypes suggesting 
additional components critical for normal somitogenesis may also be compromised. In 
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addition to the Notch pathway, the Wnt, FGF, Shh, and BMP developmental pathways 
are key participants in MPC regulation and somitogenesis (Niwa et al., 2011; 
Tiedemann et al., 2012). We postulate that Rbm24a and Rbm24b may similarly act 
upon targets within these pathways as a normal component of somitogenesis but also 
recognize that their effects may not be restricted to these pathways. 
Of those RBM members for whom functional data exists, several have been 
shown to be necessary for normal post-transcriptional processing. Indeed depletion of 
RBM4, RBM5, RBM11, RBM20 and RBM25are known to be involved in aberrant 
post-transcriptional processing, and have been identified as splicing factors for known 
targets (Gao et al., 2011; Guo et al., 2012; Jin et al., 2012; Li et al., 2013; Lin and Tarn, 
2011; Pedrotti et al., 2012).  Functional characterization of RBM9 has lead to the 
classification of this protein as a FOX family splicing factor and the re-naming of this 
protein as FOX2 (Yeo et al., 2009; Zhang et al., 2008). 
Our focus on somitic expression of Notch-pathway components, lead us to 
identify aberrant transcripts of the dlc and dld in rbm24aMO and rbm24bMO embryos.  
These aberrant transcripts resulted from the joining of distant truncated exons and 
skipping of several exons including those encoding domains required for Notch Delta 
ligand-receptor binding.  The sequences flanking all possible break points for truncated 
exons did not reveal any cryptic splice sites, suggesting an alternate means of splice site 
recognition in the absence of normal levels of Rbm24a an Rbm24b. Our data suggest 
Rbm24a and Rbm24b normally act to impact proper processing of dlc and dld 
transcripts.  This is supported by the reports that the product of SUP-12, the RBM24 
homolog in C. elegans, acts as a splicing factor in muscle (Anyanful et al., 2004; 
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Kuroyanagi et al., 2007; Ohno et al., 2012).  Our data implicates Rbm24a and Rbm24b 
in dlc and dld post-transcriptional processing. It is also likely that other transcripts, not 
necessarily associated with Notch signaling, are yet to be discovered. While we cannot 
be sure of a direct interaction relationship, all of our findings implicate both Rbm24a 
and Rbm24b in the modulation of the Notch-signaling pathway.  This, however, does 
not exclude the possibility that Rbm24a and Rbm24b play additional roles in 
modulating other signaling pathways that contribute to cardiovascular, skeletal muscle 
and craniofacial development. 
 
5.5 Final Remarks  
Our data add to a growing body of literature highlighting the functional 
significance of RBM genes and the value of continuing to their continued study.  This 
work provides substantial evidence that Rbm24a and Rbm24b are essential for normal 
cardiovascular development, somite biogenesis and craniofacial development.  We 
further provide evidence to support a model in which Rbm24a and Rbm24b play roles 
impacting the Notch-signaling pathway.  Specifically in the somites, Rbm24a and 
Rbm24b may play roles in post-transcriptional processing of Notch-ligand transcripts, 
dlc and dld, in turn providing a potential but as yet incomplete mechanistic explanation 
of the observed somite phenotypes. We acknowledge that although consistent with this 
model, it remains possible that depletion of Rbm24a and Rbm24b in the embryo causes 
primary/secondary effects on other developmentally critical pathways that may also 
contribute to these phenotypes.  
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The critical role for rbm24 in cardiogenesis raises the question whether 
mutations at the homologous human locus may contribute to cardiac disorders. 
Interestingly, Wessels et al. recently identified a novel cardiac syndrome with 
noncompaction cardiomyopathy, bradycardia, pulmonary stenosis, atrial septal defects, 
and heterotaxy with genetic linkage to human chromosome 6p (Wessels et al., 2008).  
Genome-wide linkage analysis localized the implicated interval to chromosome 6p24.3-
21.2, a region encompassing the human RBM24 homolog (6p22.3), making it an ideal 
candidate for variation underlying this phenotype.  However, sequencing of all RBM24 
coding exons, intron/exon boundaries and the upstream promoter region in two 
affecteds, revealed only known polymorphisms (rs10456798 and rs35860841) that were 
also observed in a heterozygous state in an unaffected family member. While we can 
exclude a role for RBM24 coding mutations, additional sequencing of putative 
regulatory sequences will be necessary to determine if RBM24 may play a role in this 
syndrome.   
The studies described in this work have utilized translation blocking MO 
technology in zebrafish as a powerful tool to begin functional characterization of 
Rbm24a and Rbm24b.  We are cognizant that such MOs provide a surrogate for but not 
precise equivalent of an in vivo genetic model.  Translation blocking MOs can inhibit 
both maternal and zygotic transcripts (Bill et al., 2009).  Hence, in future we are 
interested in characterizing the zygotic phenotype achieved through the generation of 
targeted mutant models.  We will continue elucidate the role and mechanisms of rbm24 
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Zebrafish dlc RT-PCR short_1 alignment to NM_ 130944 
Primers used for RT-PCR are highlighted in yellow 
dlc wt 1     GGGTTTTGAAGAAACGTAACTGAAGGGTCCAAAGTCCCCTGGAGCTAGAA  50 
dlc wt 51    ATCTGTTTTTATTTGCTTTGTAGGCTCCAAACACATGCGACATTGAGATA  100 
dlc wt 101   CATTTTTATAAGAAATGTTCATTCGTTTAACTTTTTAACTTTACGCATTT  150 
dlc wt 151   TTACAACTACTTTTTCCCTTTAAATTGTGGATAATACTTCAAACATTCAT  200 
short_1                                                        T 
 
dlc wt 201   ATCGGACTACTCTCACAGTCTGCTATCGTTCAGTAGCAGACAAGAAGGCA  250 
short_1       ATCGGACTACTCTCACAGTCTGCTATCGTTCAGTAGCAGACAAGAAGGCA 
 
dlc wt 251   AAGATGGCTCGTGTTTTATTAACGTGCTTTTTTATTTTGATATCATCGCA  300 
short_1       AAGATGGCTCGTGTTTTATTAACGTGCTTTTTTATTTTGATAT------- 
 
dlc wt 301   TCTGGGGAAATCATCCGGTGTGTTTGAGTTGAAAGTTCTGTCTTTCACAA  350 
short_1       -------------------------------------------------- 
 
dlc wt 351   GCACGAGCAGTGTGTGTAAAGGGTCCAGCGACTGCCAGATCTTTTTCCGT  400 
short_1       -------------------------------------------------- 
 
dlc wt 401   GTTTGCCTGAAGCACTCGCAAGCACTCATATTACCTGAGCCGCCGTGCAC  450 
short_1       -------------------------------------------------- 
 
dlc wt 451   CTACGGCACCGGAATGTCAGAAATACTGAGCGCGGACTCCATCTCCAGCA  500 
short_1       -------------------------------------------------- 
 
dlc wt 501   GTGCGTATATAAGCGTGCCTTTTAATTTCAAGTGGCCGGGAATCGTCTCT  550 
short_1       -------------------------------------------------- 
 
dlc wt 551   TTGATAATCGAAACCTGGAACGCAGAAACCTCTGACCAGTCAACAGAGAA  600 
short_1       -------------------------------------------------- 
 
dlc wt 601   TAACAACAACATGATAAGCCGTTTGGCCACCAAAAGAAGACTCGCTATCA  650 
short_1       -------------------------------------------------- 
 
dlc wt 651   GTGAGGACTGGTCTCAGGACGTGCATCTCGGTCGACAAAGCCAACTGCGC  700 
short_1       -------------------------------------------------- 
 
dlc wt 701   TTTTCTTATCGTGTCGTGTGCGATGAATTCTACCACGGCGAGGAATGCTC  750 
short_1       -------------------------------------------------- 
 
dlc wt 751   GGATTTCTGCCGCCCACGGAATGATACCTTCGGCCACTTCAACTGTGACG  800 
short_1       -------------------------------------------------- 
 
dlc wt 801   CCGCTGGCAACAGAATTTGCCTTCCTGGATGGAAAGGCGATTATTGCACC  850 
short_1       -------------------------------------------------- 
 
dlc wt 851   GAACCCATCTGCTTGTCTGGCTGTAGTGAGGAGAACGGTTATTGTGAGGC  900 
short_1       -------------------------------------------------- 
 
dlc wt 901   CCCCGGTGAGTGCAAGTGCCGGATTGGATGGGAAGGCCCCCTCTGTGATG  950 
 110 
short_1       -------------------------------------------------- 
 
dlc wt 951   AGTGCACGCGGCACCCGGGGTGCTTGCATGGCACCTGCAACCAGCCTTTT  1000 
short_1       -------------------------------------------------- 
 
dlc wt 1001  CAGTGCACTTGCAAAGAAGGTTGGGGCGGTCTGTTTTGCAATGAGGATCT  1050 
short_1       -------------------------------------------------- 
 
dlc wt 1051  GAACTTTTGCACTAATCACAAGCCCTGTAGAAATGACGCCACGTGTACCA  1100 
short_1       -------------------------------------------------- 
 
dlc wt 1101  ACACCGGCCAGGGCAGCTACACCTGCATTTGCAAGCCTGGCTTCAGTGGC  1150 
short_1       -------------------------------------------------- 
 
dlc wt 1151  AAAAACTGTGAGATCGAAACCAATGAGTGTGACAGCAACCCCTGCAAGAA  1200 
short_1       -------------------------------------------------- 
 
dlc wt 1201  TGGAGGCAGTTGCAATGACCAGGAGAATGATTACACTTGTACATGCCCGC  1250 
short_1       -------------------------------------------------- 
 
dlc wt 1251  AAGGCTTCTATGGCAAGAACTGCGAGGTCAGCGCCATGACCTGTGCCGAT  1300 
short_1       -------------------------------------------------- 
 
dlc wt 1301  GGACCCTGCTTCAATGGTGGAACCTGCATGGAGAAGGGATCCGGTAGCTA  1350 
short_1       -------------------------------------------------- 
 
dlc wt 1351  TTCCTGCCGCTGCCCTCCTGGATACATGGGCTCCAACTGTGAGAAGAAAA  1400 
short_1       --------------------------------------------------- 
 
dlc wt 1401  TCGACCGGTGCAGCAGTGACCCCTGTGCTAACGGTGGCCAGTGTCTCGAT  1450 
short_1       -------------------------------------------------- 
 
dlc wt 1451  TTGGGCAACAAAGCGACGTGCCGTTGCCGGCCCGGGTTCACAGGCTCACG  1500 
short_1       -------------------------------------------------- 
 
dlc wt 1501  TTGTGAAACAAACATTGACGACTGCTCAAGCAACCCCTGTCAAAATGCAG  1550 
short_1       -------------------------------------------------- 
 
dlc wt 1551  GCACCTGCGTGGATGGTATCAACGGGTACACCTGCACATGCACGCTTGGT  1600 
short_1       -------------------------------------------------- 
 
dlc wt 1601  TTCTCAGGCAAGGACTGTAGGGTTCGCTCTGACGCCTGCAGTTTCATGCC  1650 
short_1       -------------------------------------------------- 
 
dlc wt 1651  CTGCCAGAACGGAGGAACCTGCTACACTCACTTCTCTGGGCCTGTCTGCC  1700 
short_1       -------------------------------------------------- 
 
dlc wt 1701  AGTGCCCGGCAGGCTTCATGGGCACACAGTGCGAGTACAAACAGAAGCCC  1750 
short_1       -------------------------------------------------- 
 
dlc wt 1751  ACGCCTGTGAACAGCCCTGCTCTTCCAGCAGCCTTAATAGTCTCATTTAC  1800 
short_1       -------------------------------------------------- 
 
dlc wt 1801  TCTAGGCCTCATTACTCTGACCTTAGTGATCTGTGCTGCCATTGTGGTCC  1850 
short_1       -------------------------------------------------- 
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dlc wt 1851  TGCGACAGATGCGTCAGAACCACAAAGCCAGCTCAACCACAGTTCGAAAC  1900 
short_1       -------------------------------------------------- 
 
dlc wt 1901  AACCTGGATTCTGTCAATAATCGCATTTCTTTGAGCCCAACCTCACCTTT  1950 
short_1       ------------------AATCGCATTTCTTTGAGCCCAACCTCACCTTT 
 
dlc wt 1951  AGGTAGAGAGAAGGAGGCCTTCCTTATTCCTGGTGGCCCATTTAAGGTGT  2000 
short_1       AGGTAGAGAGAAGGAGGCCTTCCTTATTCCTGGTGGCCCATTTAAGGTGT 
 
dlc wt 2001  CCAATAAAGATATGGCGCTCAGATCCACCTCTGTAGACACACATTCCAGT  2050 
short_1       CCAATAAAGATATGGCGCTCAGATCCACCTCTGTAGACACACATTCCAGT 
 
dlc wt 2051  GACAAATCAAACTATAAGCAGAAGATGGTGGACTACAATCTGAGCATTGA  2100 
short_1       GACAAATCAAACTATAAGCAGAAGATGGTGGACTACAATCTGAGCATTGA  
 
dlc wt 2101  TGAAAAGCACACAAACAACAAACTAGAGAAAAACTCTGAATCAACATTGC  2150 
short_1       TGAAAAGCACACAAACAACAAACTAGAGAAAAACTCTGAATCAACATTGC  
 
dlc wt 2151  TGGTTCCACCTTTAAACTATCCAAAAGAGGGAGTGTATCATCCTGTGTAC  2200 
short_1       TGGTTCCACCTTTAAACTATCCAAAAGAGGGAGTGTATCATCCTGTGTAC  
 
dlc wt 2201  ATCATTCCCGAACACATAGAACAACGTGTGTTTGCTACTGAGGTATAGCA  2250 
short_1       ATCATTCCCGAACACATAGAACAACGTGTGTTTGCTACTGAGGTATAGCA 
 
dlc wt 2251  GAATTCTTCAATCTGGAGCACCTCAAACACCAGTGGGCCTGACCACAAAA  2300 
short_1       GAATTCTTCAATCTGGAGCACCTCAAACACCAGTGGGCCTGACCACA  
 
dlc wt 2301  ATGTTTACAGTCTCTAAGGACAAAAGGAAGACGTGAAGAGAGTATATATC  2350 
dlc wt 2351  ACATGCATTATATTATTTATTTATTCATGCTGCTCACTAAATGGACTACT  2400 
dlc wt 2401  TCTTGATATGGATAATGAATTTGTGAAGACAAGCAAGAGACTTGAAGACC  2450 
dlc wt 2451  CGAGGAACAACTTGCATTATTTGCACTATTTCCTTTCCCTTTTTTAATGA  2500 
dlc wt 2501  CCCAAACAGAATTTTTATATATTTGTCATCATATTTAAATTGTACATAGA  2550 
dlc wt 2551  CACAAGAACTCTCTGGAAGAGCTGAAGAATCAAGGATTTGATAATCACAG  2600 
dlc wt 2601  AAGCCTTGAAAAGGAAGAAAATAGGCATCCTGAAGTTCATCTAACTCTGT  2650 
dlc wt 2651  GAATCACATGAAGCCCAAACAATCAGCCTTATGGGTGGAGGAGGTGCAAC  2700 
dlc wt 2701  TGAAGGATCTGGAACTGTGACTGTGGAGTATTTGCCTTTTATTTTTATTT  2750 
dlc wt 2751  TTTCGATATGGTTCGAAATGCTATTTATAAATGGAACTGTGATGAGAAGC  2800 
dlc wt 2801  AATCAAACTGAACAAAACAAGTTGTTCTGGCTGTGAACAATGTGAACAAC  2850 
dlc wt 2851  TGTCTTGGAAATGTACAGTTTTATGCGGCAGTGATTTTACTTAGTGCCTA  2900 
dlc wt 2901  CAATGGATCTGACTATCAGTGACATTTTCTCAAACCAAACCCAATCTCAA  2950 
dlc wt 2951  TTAAGTGCCTCATTCTTTAATGTGCTACAGCTCAGTTACAAAGGTACTCC  3000 
dlc wt 3001  TTAGAAACACTGAAAAGAGCCTTTTTTTAAACACTATAGGAGTATGCTTT  3050 
dlc wt 3051  TCGACAGTAGATGTTTGGGTTGATTTGAGTACAGTTGTTTAAACAGCGAT  3100 
dlc wt 3101  GGATGATGGATGCTGTTGTGTACAGCGGCCATCCTGTCAACATTCACTGG  3150 
dlc wt 3151  TGGTAACTATTTCCGACATTCCCAAGGCTTGAAAGGACCCTTGGTCCAAA  3200 
dlc wt 3201  CTGATAGCCTCAACATTGTCAAGATTTCCTGGGTTTGTAATCCTCTGCAA  3250 
dlc wt 3251  TCAGAGTGTTTTTCAAAATTCACAACAACATAGATTGTTCTATGTCTTTT  3300 
dlc wt 3301  CCTTTCCTATTTTATTTTTTATTTTTTAGTATGTGGCATTTGTTCCGTCA  3350 
dlc wt 3351  TTTTCATTTTTTAAAACCCTTTAAACCCAAAGAGGTGGAACCTTTAATAT  3400 
dlc wt 3401  TTTAAACCGTTTTCCTTAATTTACCAATGCCATAAGGGCCAAATTTTTGG  3450 
dlc wt 3451  ATAATCCCCTATTTAATTGGGCCGTAAAAATTTTGGATTTATGAGAGGAT  3500 
dlc wt 3501  GAATGGATATAAGGTTAAGGATTTTGCAAATATATATATATATTTTTTCA  3550 
dlc wt 3551  AATAAATAAACCCCCGGAATAATTTAAAAAAAAAAAAAAAAAAAAAAAAA  3600 
dlc wt 3601  AAAAAAAAAA                                          3610  
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APPENDIX 3 
Zebrafish dld RT-PCR short_1 & short_2 alignment to NM_ 130955 
Primers used for RT-PCR are highlighted in yellow 
 
dld wt 1     AGTCAGTCTCTCACATGGAAACAAGAGTACGGGATGAAAGTTTGGATCAG  50 
dld wt 51    TAGTTTGGATCATCTCCACATGAACTTTTGAAACGGAAAATAAGCGCATA  100 
dld wt 101   AATAACCCTGTGCTTGGGGTTTTGTCATTTTTCCGGCTTCCTAAACTACC  150 
dld wt 151   CGAAAGTGGACTGCTAACTTTTTTTGACAACTTGGAGTACTCGACTTGTG  200 
dld wt 201   AGGGATTTCCCAATCGTCTCCCTTTTGCGCATCGGGGTTTCCTCCTTCTA  250 
dld wt 251   CATTCGTATTTGGGATTTAATTGCTGATTTATTTTCCAAGGGGGGACTTT  300 
dld wt 301   GATGGGCTTGCATGAGCAGATAAACTGAACACAACAGAGCATCAACCCGA  350 
dld wt 351   GCTGCCTCCCACTGAGCGGAGAACGACGAGTCTCAATGATTTATTGAGAC  400 
dld wt 401   ACGGTCTCACACAATTGCCTGGCCCGTGGAAGTTTCACAACAGTTCAGAT  450 
short_1                      TGCCTGGCCCGTGGAAGTTTCACAACAGTTCAGAT 
short_2                      TGCCTGGCCCGTGGAAGTTTCACAACAGTTCAGAT 
 
dld wt 451   CCTCTCCGCCATGGGACGACTAATGATAGCTGTTTTGCTTTGTGTCATGA  500 
short_1       CCTCTCCGCCATGGGACGACTAATGATAGCTGTTTTGCTTTGTGTCATGA 
short_2       CCTCTCCGCCATGGGACGACTAATGATAGCTGTTTTGCTTTGTGTCA--- 
 
dld wt 501   TAAGCCAGGGGTTTTGTTCAGGGGTTTTTGAGCTAAAGTTGCAAGAGTTT  550 
short_1       TAAGCCAGGGGTTTTGTTCAGGGGTTTTTGAGCTAAAGTTGCAAGAGTTT 
short_2       -------------------------------------------------- 
 
dld wt 551   CTGAACAAGAAAGGAGTGACAGGCAACGCAAACTGCTGCAAGGGATCCGC  600 
short_1       CTGAACAAGAAAGGAGTGACAGGCAACGCAAACTGCTGCAAGGGATCCGC 
short_2       -------------------------------------------------- 
 
dld wt 601   GGCAGAGGGTCTTCAGTGTGAATGCAAAACTTTTTTTAGGATTTGCCTGA  650 
short_1       GGCAGAGGGTCTTCAGTGTGAATGCAAAACTTTTTTTAGGATTTGCCTGA 
short_2       -------------------------------------------------- 
 
dld wt 651   AACATTACCAAGCCAACGTATCTCCAGATCCTCCGTGCACCTACGGTGGC  700 
short_1       AACATTACCAAGCCAACGTATCTCCAGATCCTCCGTGCACCTACGGTGGC 
short_2       -------------------------------------------------- 
 
dld wt 701   GCAGTTACCCCGGTGCTCGGATCAAACTCCTTCCAAGTTCCCGAAAGCTT  750 
short_1       GCAGTTACCCCGGTGCTCGGATCAAACTCCTTCCAAGTTCCCGAAAGCTT 
short_2       -------------------------------------------------- 
 
dld wt 751   CCCTGACAGCTCGTTCACCAACCCCATTCCTTTCGCGTTTGGGTTCACAT  800 
short_1       CCCTGACAGCTCGTTCACCAACCCCATTCCTTTCGCGTTTGGGTTCACAT 
short_2       -------------------------------------------------- 
 
dld wt 801   GGCCAGGAACATTTTCGCTGATTATTGAAGCGCTGCACACCGACTCCACT  850 
short_1       GGCCAGGAACATTTTCGCTGATTATTGAAGCGCTGCACACCGACTCCACT 
short_2       -------------------------------------------------- 
 
dld wt 851   GATGACCTGTCTACAGAAAACCCAGACCGTCTGATCAGTCGCATGACCAC  900 
short_1       GATGACCTGTCTACAGAAAACCCAGACCGTCTGATCAGTCGCATGACCAC 
short_2       -------------------------------------------------- 
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dld wt 901   CCAGAGGCATCTAACAGTAGGCGAGGAATGGTCCCAAGATCTACAGGTTG  950 
short_1       CCAGAGGCATCTAACAGTAGGCGAGGAATGGTCCCAAGATCTACAGGTTG 
short_2       -------------------------------------------------- 
 
dld wt 951   GTGGGAGGACAGAGCTGAAGTACTCATACAGATTCGTTTGTGATGAGCAT  1000 
short_1       GTGGGAGGACAGAGCTGAAGTACTCATACAGATTCGTTTGTGATGAGCAT 
short_2       -------------------------------------------------- 
 
dld wt 1001  TACTACGGCGAGGGCTGCTCGGTCTTCTGCCGTCCGCGCGATGATACTTT  1050 
short_1       TACTACGGCGAGGGCTGCTCGGTCTTCTGCCGTCCGCGCGATGATACTTT 
short_2       -------------------------------------------------- 
 
dld wt 1051  CGGCCACTTCACCTGCGGAGAGCGCGGAGAAATTATCTGCAACTCCGGAT  1100 
short_1       CGGCCACTTCACCTGCGGAGAGCGCGGAGAAATTATCTGCAACTCCGGAT 
short_2       -------------------------------------------------- 
 
dld wt 1101  GGAAAGGACAGTACTGCACAGAACCAATCTGTCTTCCGGGGTGTGATGAA  1150 
short_1       GGAAAGGACAGTACTGCACA------------------------------ 
short_2       -------------------------------------------------- 
 
dld wt 1151  GACCATGGCTTTTGCGACAAACCCGGTGAATGCAAATGCAGAGTAGGATT  1200 
short_1       -------------------------------------------------- 
short_2       -------------------------------------------------- 
 
dld wt 1201  TAGTGGAAAGTACTGTGACGACTGCATTCGCTACCCAGGCTGCTTGCATG  1250 
short_1       -------------------------------------------------- 
short_2       -------------------------------------------------- 
 
dld wt 1251  GCACCTGCCAACAGCCCTGGCAATGCAACTGCCAAGAGGGTTGGGGAGGT  1300 
short_1       -------------------------------------------------- 
short_2       -------------------------------------------------- 
 
dld wt 1301  CTCTTCTGTAACCAAGATCTCAATTACTGCACACATCACAAACCGTGCCA  1350 
short_1       -------------------------------------------------- 
short_2       -------------------------------------------------- 
 
dld wt 1351  GAATGGAGCCACTTGCACCAACACAGGCCAGGGAAGCTACACCTGCTCAT  1400 
short_1       -------------------------------------------------- 
short_2       -------------------------------------------------- 
 
dld wt 1401  GCAGACCTGGCTTCACCGGGGACAGCTGTGAGATTGAGGTCAACGAATGC  1450 
short_1       -------------------------------------------------- 
short_2       -------------------------------------------------- 
 
dld wt 1451  TCCGGCAGCCCGTGCAGAAATGGAGGAAGTTGCACTGATCTTGAAAACAC  1500 
short_1       -------------------------------------------------- 
short_2       -------------------------------------------------- 
 
dld wt 1501  CTACAGCTGCACTTGTCCTCCTGGTTTCTACGGAAGAAACTGCGAGCTGA  1550 
short_1       -------------------------------------------------- 
short_2       -------------------------------------------------- 
 
dld wt 1551  GTGCCATGACTTGTGCCGACGGCCCCTGCTTCAATGGTGGACAGTGTGCT  1600 
short_1       -------------------------------------------------- 
short_2       -------------------------------------------------- 
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dld wt 1601  GACAACCCAGAGGGAGGATATTTCTGCCAGTGCCCGATGGGTTATGCTGG  1650 
short_1       -------------------------------------------------- 
short_2       -------------------------------------------------- 
 
dld wt 1651  ATTCAACTGTGAGAAGAAGATCGATCACTGCAGCTCCAACCCTTGCTCGA  1700 
short_1       -------------------------------------------------- 
short_2       -------------------------------------------------- 
 
dld wt 1701  ATGATGCTCAGTGTCTCGATCTTGTGGACTCCTATCTTTGCCAGTGTCCT  1750 
short_1       -------------------------------------------------- 
short_2       -------------------------------------------------- 
 
dld wt 1751  GAGGGATTCACAGGAACGCACTGCGAAGACAACATCGACGAGTGTGCCAC  1800 
short_1       -------------------------------------------------- 
short_2       -------------------------------------------------- 
 
dld wt 1801  CTATCCCTGCCAGAATGGCGGCACTTGCCAAGACGGACTCAGCGACTACA  1850 
short_1       -------------------------------------------------- 
short_2       -------------------------------------------------- 
 
dld wt 1851  CCTGCACCTGCCCGCCTGGATACACCGGCAAGAACTGCACCTCTGCGGTC  1900 
short_1       -------------------------------------------------- 
short_2       -------------------------------------------------- 
 
dld wt 1901  AACAAGTGCCTCCACAACCCTTGCCACAACGGTGCCACTTGTCATGAAAT  1950 
short_1       -------------------------------------------------- 
short_2       -------------------------------------------------- 
 
dld wt 1951  GGACGGTCGATATGTGTGCGCTTGCATCCCAGGTTATGGAGGACGCAACT  2000 
short_1       -------------------------------------------------- 
short_2       -------------------------------------------------- 
 
dld wt 2001  GTCAGTTCTTACTCCCTGAAAACCCACAAGGACAAGCCATCGTTGAGGGA  2050 
short_1       -------------------------------------------------- 
short_2       -------------------------------------------------- 
 
dld wt 2051  GCCGACAAGAGATACTCTTACGAAGAAGACGACGGTGGTTTTCCATGGAC  2100 
short_1       -------------------------------------------------- 
short_2       -------------------------------------------------- 
 
dld wt 2101  GGCGGTTTGCGCTGGGATTATTTTAGTGCTTTTAGTGCTGATCGGCGGCT  2150 
short_1       -------------------------------------------------- 
short_2       -------------------------------------------------- 
 
dld wt 2151  CCGTCTTTGTCATTTACATCCGTCTCAAGCTGCAGCAGAGGAGCCAGCAA  2200 
short_1       -------------------------------------------------- 
short_2       -------------------------------------------------- 
 
dld wt 2201  ATCGATAGCCATAGTGAAATCGAGACCATGAACAACCTGACCAACAACCG  2250 
short_1       -------------------------------------------------- 
short_2       -------------------------------------------------- 
 
dld wt 2251  CAGCCGAGAGAAGGACTTGTCCGTAAGCATCATCGGAGCCACGCAAGTGA  2300 
short_1       -------------------------------------------------- 
short_2       -------------------------------------------------- 
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dld wt 2301  AAAACATCAACAAGAAAGTGGACTTTCAGAGCGACGGCGACAAAAACGGA  2350 
short_1       -------------------------------------------------- 
short_2       -------------------------------------------------- 
 
dld wt 2351  TTCAAATCGCGATACTCGCTAGTGGATTACAATCTTGTTCATGAGCTGAA  2400 
short_1       -------------------------------------------------- 
short_2       -------------------------------------------------- 
 
dld wt 2401  GCAGGAGGACTTGGGGAAAGAGGATTCTGAGAGGAGCGAAGCCACAAAAT  2450 
short_1       -------------------------------------------------- 
short_2       -------------------------------------------------- 
 
dld wt 2451  GCGAGCCTCTCGATTCCGACTCAGAGGAGAAGCACAGAAATCATTTAAAA  2500 
short_1       -------------------------------------------------- 
short_2       --------------------------GAGAAGCACAGAAATCATTTAAAA 
 
dld wt 2501  AG------------------------------------------------  2502 
short_1       -------------------------------------------------- 
short_2       AGgtaaatgagtgtgaattttggctagcgcagatccatttgtcgatgtaa 
 
dld wt 2503  --------------------------------TGACTCCTCAGAGAGGAA  2520 
short_1       -------------------------------------------------- 
short_2       gcagtactaaagttgcctcttttcgttttcagTGACTCCTCAGAGAGGAA 
 
dld wt 2521  ACGAACAGAATCTTTGTGCAAGGACACAAAGTACCAGTCAGTCTTTGTTT  2570 
short_1       -------------------------------------------------- 
short_2       ACGAACAGAATCTTTGTGCAAGGACACAAAGTACCAGTCAGTCTTTGTTT 
 
dld wt 2571  TATCAGAGGAGAAAGATGAATGTATTATTGCAACCGAGGTGTAACGCCAC  2620 
short_1       -------------------------------------------------- 
short_2       TATCAGAGGAGAAAGATGAATGTATTATTGCAACCGAGGTGTAACGCCAC 
 
dld wt 2621  AACAGAGCTGTAGCTCATCTTGTTCTACAGGAGGTTTTACTCCAGTAATG  2670 
short_1       -ACAGAGCTGTAGCTCATCTTGTTCTACAGGAGGTTTTACTCCAGTAATG 
short_2       AACAGAGCTGTAGCTCATCTTGTTCTACAGGAGGTTTTACTCCAGTAATG 
 
dld wt 2671  CTGCTCAAACCAGAGGGAAGGTTCCCTTCACGTGACTGCTGCTGTGAAAC  2720 
short_1       CTGCTCAAACCAGAGGGAAGGTTCCCTTCACGTGACTGCTGCTGTGAAAC 
short_2       CTGCTCAAACCAGAGGGAAGGTTCCCTTCACGTGACTGCTGCTGTGAAAC 
 
dld wt 2721  TAATGTTGAAGGTGATATTCAGAATGAGCTGGTTCTCAACTGAAGTAAAC  2770 
short_1       TAATGTTGAAGGTGATATTCAGAATGAGCTGGTTCTCAACTGAAGTAAAC 
short_2       TAATGTTGAAGGTGATATTCAGAATGAGCTGGTTCTCAACTGAAGTAAAC 
 
dld wt 2771  ACAGTGACTGCAGGAAAGGACGTTGGGCCATACTGGCTCGGACTCTCAAA  2820 
short_1       ACAGTGACTGCAGGAAAGGACGTTGGGCCATACTGGCTCGG 
short_2       ACAGTGACTGCAGGAAAGGACGTTGGGCCATACTGGCTCGG 
 
dld wt 2821  GTTTGTTTCCCAGGAACGTGCCAAATGGACTTGCTTGCACTTCCTGTAGG  2870 
dld wt 2871  GACGTTTTTTTTTTACCTCATTGCACTATGATGGGTTGTATTTTTATTGT  2920 
dld wt 2921  ATTTAACACACAATTGAATCGAATACTGTGTATGCATATGCACTGACTGC  2970 
dld wt 2971  AGTGTGCATCTGGAAGTTCTCGGATCCTTGGATCGCGAGAGGAAGAACAC  3020 
dld wt 3021  TGCCATCAATGATGTTTGTAACTGATTCGTTGTTTTATTTTCGGAAAGCT  3070 
dld wt 3071  TGTGTTTTCTTTATTTAAATGTTATTTGTGATCGACGTGTTTGTGGTTTA  3120 
dld wt 3121  CTTTGTGTGTGTGTGTGTGTGAAGTTTGATATAATTTAAAATCTTTTTTT  3170 
dld wt 3171  CATTTCGCAGATATGTCTATTGTAAATAAGGCACTTCGGGTCGACGTGAC  3220 
 116 
dld wt 3221  TGTTCTCTGTAAATGTATTTAAACGTGCTGGTAAAACTTACAGGAGTTGT  3270 
dld wt 3271  TTTTATGACTGTTGTCCAATGAAAAAAAAATCACCTTAATATTTTTCCAA  3320 
dld wt 3321  ATAAATCCTGTATGAAACTTCAAAAAAAAAAAAAAAAAAAAAAAAAAAAA  3370 
dld wt 3371  AAAAAAA                                             3377 
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Curriculum vitae 
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